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ABSTRACT
Vaccinia virus, the prototype member of the orthopoxviruses, is the largest and the most
complex virus known. After replication of its genome and expression of the viral proteins,
vaccinia undergoes a complicated assembly process which produces two distinct infectious
forms. The frrst of these, the intracellular mature virus (IMV), develops from the immature
virion (IV) after packaging of the genome and cleavage of the core proteins. During the
transition of the IV to the IMV, a new core structure develops in the centre of the virion,
concomitantly with the appearance of spike-like structures which extend between this core and
the surrounding membranes of the IMV. I describe the characterization ofp39 (gene A4L)
which is hypothesized to be one component of these spikes. p39 is a core protein, but has
strong associations with the membranes surrounding the IMV, possibly due to an interaction
with p21 (A17L). Due to its location between the core and the membranes of the IMV, p39 is
ideally situated to act as a matrix-like linker protein and may playa role in the formation of the
core during the transition of the IV to the IMV.
The IMV is subsequently wrapped by a membrane cisterna derived from the trans Golgi
network, to form the intracellular enveloped virus (lEV). I show that the lEV can co-opt the
actin cytoskeleton of the host cell in order to induce the formation of actin tails which extend
from one side of the virion. These actin tails propel the virus particle, both intra- and
intercellularly, at speeds of up to 2.8fJ.ID1min. On reaching the plasma membrane, the virus
particles project out from the cell surface at the tip of virally induced microvilli. The outer
membrane of the lEV is thought to fuse with the plasma membrane at the tip of these
projections, thus exposing the second infectious form of vaccinia. This is thought to be the
means by which the cell-associated enveloped virus is presented to neighbouring cells, thereby
facilitating the direct cell-to-cell spread of virus particles.
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Introduction
Introduction
The work presented in this thesis encompasses two different stages of the life cycle of
vaccinia virus; (i) the early stages of vaccinia assembly and (ii) the actin-based motility of
vaccinia virus. In this introduction I will present a brief synopsis of the life cycle of vaccinia
and, as a basis for comparison with vaccinia motility, I will review the field of actin-based
bacterial motility as there are many parallels, as well as differences, between the two
systems.
1.1 Poxviridae
The poxviridae form a diverse family of DNA viruses which infect both vertebrate
and invertebrate hosts. They are the largest known viruses, reaching sizes of approximately
200nm in width x 400nm in length. Pox virions consist of a double stranded DNA genome
of between 130 and 280kbp, which is surrounded by a number of membranes of different
~
sub-cellular origin. The poxviruses encode Aot the proteins required for their own replication
and transcription, which occurs independently of the host cell nucleus, unlike other DNA
viruses (Moss, 1990). Mw members of the poxviridae which have been investigated thus far
have two distinct infectious forms, the intracellular mature virus (IMV) and the extracellular
enveloped virus (BEV), which appear at different stages during the life-cycle.
A scheme depicting the members of the poxvirus family is shown in figure 1. The
poxviridae consist of two subfamilies, Chordopoxvirinae (vertebrate poxviruses) and
Entomopoxvirinae (insect poxviruses). The Chordopoxvirinae are further divided into eight
genera; orthopoxvirus, parapoxvirus, avipoxvirus, capripoxvirus, leporipoxvirus,
suipoxvirus, yatapoxvirus and molluscipoxvirus (Murphy and Kingsbury, 1990). The most
well known of these genera is orthopoxvirus, which is comprised of variola virus, the
causative agent of human smallpox, as well as vaccinia virus, cowpox virus and monkeypox
virus. The members of the orthopox 3U1us are famous for a number of different reasons.
Smallpox has been known as a severe disease for over 2000 years. Originating in India or
western Asia, smallpox spread to eastern Asia, Europe and north Africa by 700AD. From
Europe it was spread to most of the rest of the world by colonisers, arriving in North
America in 1617 and Australia in 1789 (Fenner, 1990). Smallpox was one of the fIrSt
diseases against which preventative measures were taken. In ancient China dried material
was taken from skin lesions of people recovering from a mild infection and this was
administered to other individuals by inhalation, a process known as variolation, varus being
the Latin for pimple. Vaccination, as we know it today, was pioneered by Edward Jenner
(*1749-1823t). He used material from the pocks of milk maids infected with cowpox which
he then injected into uninfected people to confer immunity against smallpox (Jenner, 1799).
Hence the name vaccination which is derived from vacca, the Latin word for cow. Due to a
2
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global eradication programme co-ordinated in 1958 by the World Health Organization
(WHO), the world was declared free of endemic smallPOJl in 1979 (WHO, 1980).
VIRUSES
PLANT ANIMAL BACTERIA
__ ~1Z2::::cc::::-z~__
POX
..
Parapox
•
Suipox Avipox ORTHOPOX Leporipox Capripox Mollu8Cipox
V8rlol8 Cow,.- VACCINIA Monkeypox
IHD-W IHD-J Wyeth WR Lister TianTan Copenhagen
FIGURE 1: A tree diagram depicting the members of the poxvirus family
1.2 Vaccinia Virus
Vaccinia virus is the prototyPe mem':i.oJ tM~ ~tf90poxvintses. It was the first viros
to be seen microscopically (in 1887 by Buist)"to be associated with an infectious disease
(Ledingham and Aberd, 1931), accurately titrated, physically purified and chemically
analysed (Craigie, 1932; Ledingham and Aberd, 1931). The main constituents of vaccinia
virus are protein, lipid and DNA which account for 90%,5-6% and 3.2% respectively oftbe
dry weight of the particle (Zwartouw, 1964). Vaccinia is a valuable tool which is used as an
expression system, and recombinant vaccinia is being considered for use as a live vaccine
against many diseases, including herPeS and AIDS (Moss, 1991). There are a number of
different vaccinia strains which include WR (Western Reserve), COPenhagen, Lister, Wyeth,
llID-J, llID-W (International Health Department) and Tian Tan (figure 1).
3
Introduction
The ends of the genome consist of terminal hairpin loops which covalently connect
the two DNA strands into one continuous polynucleotide chain (Baroudy et al., 1982). The
genome of vaccinia strain Copenhagen is composed of 191kbp of a linear duplex DNA
molecule. This genome has been completely sequenced and shown to code for a potential
263 open reading frames, which encode proteins of over 65 amino acids (Goebel et al., 1990;
Johnson et al., 1993). However many of the proteins encoded by these genes still await
identification and functional characterization.
1.3 Vaccinia life cycle
For ease of description, the life cycle of vaccinia virus will be reviewed under the
following headings; virus entry, regulated gene expression and replication of the dsDNA
genome, virion assembly and virus dissemination. Figure 2 shows a general scheme
depicting the life cycle.
1.3.1 Vaccinia entry
There are a number of different stages in vaccinia entry: adsorption, penetration and
uncoating. First vaccinia adsorbs to the cell surface. This may occur due to an interaction
with a receptdt on the plasma membrane, however a receptor for vaccinia virus has
DNA core
RNA polymer••
potylA) polymerase
capping enzyme
methylating enzvm-
EEV
FIGURE 2: Outline of the life-cycle of vaccinia virus (modified from Moss, 1990)
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not yet been identified 1. Adsorption to the cell surface can occur at 4°C whereas
penetration, the second stage of entry, requires physiological temperatures. Enveloped
viruses normally penetrate cells either by fusion of their outer membrane with the plasma
membrane or alternatively they can be endocytosed, whereupon low pH triggers a
conformational change in a viral fusion protein leading to fusion of the viral membrane with
the endosomal membrane, releasing the nucleocapsid (for a review see Marsh and Helenius,
1989). Fusion with the plasma membrane is currently accepted as the method of vaccinia
penetration (Doms et al., 1990). Due to the fact that vaccinia has two infectious forms (see
section 1.4), the intracellular mature virus (IMV) and the extracellular enveloped virus
(BEV), the process of vaccinia entry is complicated. Early work on vaccinia virus used
preparations of IMV as the importance of the EEV for infection had not been recognized.
Electron micrographs show IMVs fused to the plasma membrane (Chang and Metz, 1976) or
within vacuoles formed by membrane invagination (Dales and Kajioka, 1964). Fluorescence
assays have also demonstrated that vaccinia membranes fuse with the plasma membrane
(Doms et al., 1990). In addition, other reports have suggested that vaccinia virus is activated
by interaction with the plasma membrane (Ichihashi and Oie, 1983) and viral proteins are
found associated with the plasma membrane after subcellular fractionation of infected cells
(Janeczko et al., 1987; Mallon (Ruszala) and HolowcZ8C, 1985). In agreement, plaque
formation is not inhibited by lysomotrophic agents indicating that endocytosis is not
essential for vaccinia entry (Doms et al., 1990; Janeczko et al., 1987).
There is very little information concerning the entry of the EEV, which has an
additional membrane in comparison to the IMV. Current understanding is that enveloped
virus is essential for cell-to-cell and long range spread of the virus (Appleyard et al., 1971;
Blasco and Moss, 1991; Blasco and Moss, 1992; Boulter and Appleyard, 1973; Payne,
1980). EEV fuses twice as rapidly and efficiently with cell surfaces than the IMV (Doms et
al., 1990; Payne and Norrby, 1978). According to this model, an IMV would be released
into the cytoplasm and therefore it is likely that a different mechanism of virion disassembly
exists in order to release the viral cores after EEV entry.
The third step in vaccinia entry involves uncoating of the virus core to release the
DNA. Unlike the earlier two steps of vaccinia entry, it requires both viral RNA and protein
synthesis (Joklik, 1964). It is thought that an early viral protein, a putative 23kD uncoating
protein with trypsin-like activity, may be involved in this uncoating process (Pedley and
1 It has been proposed, based on infectivity-blocking studies with epidermal growth factor (EGF), synthetic
peptides and antibodies to the EGF receptor (EGF-R), that the EGF-R acts as a portal of entry for vaccinia virus
(Eppstein et aI., 19985; Marsh and Eppstein, 1987). However, it has been shown more recently that EGF-R is
not a receptor for vaccinia (Hugin and Hauser, 1994; Stroobant et aI., 1985).
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Cooper, 1987). Isolated cores can be purified and have been shown to be capable of in vitro
transcription (Kates and McAuslan, 1967; Kates and Beeson, 1970; Munyon et al., 1967).
The cores contain all the proteins necessary for this process e.g.,VETF ~oc.c,;"uly
transcription factor) (Li and Broyles, 1995), RNA polymerase (Kates and McAuslan, 1967),
deoxyribonuclease (Pogo and Dales, 1969), nucleoside triphosphate phosphohydrolase (Gold
and Dales, 1968) and DNA topoisomerase (Bauer et al., 1977). The core of vaccinia can be
visualized by electron microscopy as a distinct physical entity in the cytoplasm of the
infected cell and it appears that the nucleoprotein complex passes out through a breach in the
wall of this core, leaving behind empty shells (Dales, 1965; Dales, 1963; Dales and Kajioka,
1964).
1.3.2 Gene expression and DNA replication
Vaccinia gene expression is divided into three groups on a temporal basis; the early
genes are transcribed prior to DN:A replication 2, while the transcription of both the
dur"" ffintermediate and late genes occur~atterDNA replication (Moss, 1990; Moss, 1990; Moss,
1990). Transcription of the early genes by enzymes which are present in the core produces
functional mRNA (Kates and McAuslan, 1967). These early genes encode proteins such as
the putative uncoating protein (Pedley and Cooper, 1987), growth factors (Stroobant et al.,
1985) and DNA polymerase (Challberg and Englund, 1979). Once the virion has been
uncoated, the DNA released and early gene expression has taken place, genome replication
can commence.
As previously mentioned, the transcription and replication of the vaccinia genome
takes place in the cytoplasm of the host cell. This occurs in structures called "viral factories"
which are found in the perinuclear region of infected cells approximately 1 to 2 hours after
infection (Cairns, 1960; Dales, 1963; Harford et al., 1966; Minnigan and Moyer, 1985).
DNA replication commences at about 1.5 h after infection (Cairns, 1960) and by 4.5h, 90%
of the replication has occurred (Joklik and Becker, 1964). Cells infected with vaccinia
contain up to six times more DNA polymerase activity than uninfected cells, despite the fact
that the replication of the host cell nuclear DNA is greatly diminished (Green and Pina,
1962; Joklik and Becker, 1964; Magee, 1962). Up to 10,000 copies of the viral genome are
generated per infected cell (Joklik and Becker, 1964; Salzman, 1960).
Coincident with the onset of DNA replication, a dramatic change in gene expression
occurs as the intermediate and late genes are switched OD. The intermediate proteins are
2 These early genes account for approximately half of the genome. 1be transcription of the early genes
continues, to a lesser extent, even after the late genes have been switched on (Boone and Moss, 1978; Oda and
Joldik, 1967; Paoletti and Grady, 1977).
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synthesised immediately after DNA replication, whereas the synthesis of the late proteins is
somewhat delayed (Moss, 1990). The late genes encode most of the structural proteins
which are needed for virion assembly, as well as many different enzymes including a DNA
topoisomerase (Bauer et al., 1977) and deoxyribonucleases (McAuslan and Kates, 1967;
Pogo and Dales, 1969).
1.3.3 Virion assembly and release
Once genome replication and protein synthesis have occurred, virion assembly can
commence. The frrst sign of viral membrane formation is the appearance of rigid, curved
membrane structures called "crescents" (see figure 2), which apPear to bud from the viral
factories, already described as the sites of DNA replication. These "crescents" consist of a
membrane with a border of spicules on the convex surface and electron dense granular
material on the concave surface (Dales, 1963). It is believed by some that these crescents are
synthesised de novo in the cell, without a pre-existing membrane template, as they do not
appear to have any definite continuation with membranes from cellular organelles (Stem and
Dales, 1974; Stem and Dales, 1976; Mohondas and Dales, 1995). However, it was shown by
Sodeik (1993) that these membranes are derived from a cisterna of the intermediate
compartment (Ie) and that they are therefore composed of two tightly apposed membrane
bilayers. These membranes have a very rigid structure and it is thought that p65, the gene
product of D13L, may contribute to this rigidity as it localizes to the concave surface of the
"crescents". In the presence of the drug rifampicin, p65 fails to localize to the membranes
surrounding the viral factories and the crescents do not form (see sections 1.4.1 and I.S)
(Essani et al., 1982; Sodeik et al., 1994).
The crescents develop into completely spherical immature virions (IV) which
undergo further maturational changes, such as the packaging of DNA and cleavage of core
proteins (Moss and Rosenblum, 1973; VanSlyke et al., 1991; VanSlyke et al., 1991), to
produce the frrst of two infectious forms of vaccinia, the intracellular mature virus (IMV),
which are fmt seen about 3 to 4 hours after infection. Almost nothing is known about the
transition from the IV to the IMV. Whereas the IV is completely spherical and has not yet
packaged its complement of DNA, the IMV is a parallelepiped with a definite internal core
structure. Release of IMV can occur when the cell lyses due to the cytotoxic effects of
infection.
A fraction of IMV, varying between 5 and 40% according to vims strain and cell type
(payne, 1979), can undergo a second wrapping step by another membrane cisterna (Dales,
1971; Hiller and Weber, 1985; Ichihashi et al., 1971; Morgan, 1976), this time from the trans
Golgi network (TON) (Schmelz et al., 1994), producing the intracellular enveloped virus
7
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(lEV) (figure 2). The lEV is released from the cell when its outermost membrane fuses with
the plasma membrane, thus producing the extracellular enveloped virus (BEV) (Dales, 1971;
Ichihashi et al., 1971; Morgan, 1976; Payne, 1980; Payne and Kristensson, 1985). It has
also been demonstrated that thick actin-containing microvilli, which have virus particles at
their tips, are induced at late times during infection, possibly facilitating the release of virus
particles (Hiller et al., 1981; Hiller et al., 1979; Krempien et al., 1981; Stokes, 1976).
Tht. Mo.jOfibj _of enveloped virus can remain bound to the outer cell surface and this is
referred to as cell-associated enveloped virus (CEV) (Blasco et al., 1991; Blasco and Moss,
1992). EEV is important for long range virus transmission and the ability of a given vaccinia
strain to cause long range spread of infection is directly related to the amount of EEV it
produces (Appleyard et al., 1971; Boulter and Appleyard, 1973; Payne, 1979; Payne, 1980).
It has been suggested that the CEV is involved in direct cell-to-cell spread of infection
(Blasco and Moss, 1991; Blasco and Moss, 1992).
1.4 Vaccinia virus structuraI proteins
Of the 263 potential reading frames in the vaccinia genome (Goebel et al., 1990;
Johnson et al., 1993), approximately 100 proteins are packaged into the mature virion
(Carrasco and Bravo, 1986; Essani and Dales, 1979). Many of these are post-translationally
modified by proteolytic cleavage, glycosylation, phosphorylation and fatty acid acylation
(for a review see (VanSlyke and Hruby, 1990). Vaccinia structural proteins, which are the
products of late genes, can be separated into two groups according to their location within
the virion: (i) core proteins and (ii) envelope proteins. This classification is based on the
traditional method used to separate vaccinia membranes from the cores, which employs a
combination of a detergent, usually Nonidet P 40 (NP 40), and a reducing agent, usually
either dithi0ieitol or ~-mercaptoethanol (Easterbrook, 1966; Essani and Dales, 1979;
Holowczak and Joklik, 1967; Oie and Ichihashi, 1981; Sarov and Joklik, 1972).
1.4.1 Core proteins
In combination with the structural proteins, the core also contains soluble enzymes
which are necessary for the transcription of the early genes (see section 1.3.2). The potential
structural proteins described to date are: (i) pll (gene FI8R), a basic, phosphorylated, llkD
DNA-binding protein which accounts for 11% of the total weight of the particle (Kao et al.,
1981; Pogo et al., 1975; Wittek et al., 1984). pll is implicated in the condensation of the
DNA and its incorporation into the virion (Kao and Bauer, 1987). Inactivation of the gene
demonstrated that p11 is essential for viral assembly (Zhang and Moss, 199~ Zhang and
Moss, 199.. It has also been reported that an llkD phosphorylated protein interacts with
the actin cytoskeleton, but it remains to be established if this is the same protein (Hiller and
8
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Weber, 1982). (ii) p25 (gene IAR) is a 25kD protein which is derived from a larger
precursor of 28kD (p28) by post-translational cleavage (Samv and JokJ.ik, 1972; VanSlyke et
al., 1991; Vanslyke and Hruby, 1994; Weir and Moss, 1984; Weir and Moss, 1985; Yang et
al., 1988). p25 comprises 6.5% of the virion weight and it has been suggested that it may
have a histone like-function as it can bind to DNA (Yang et al., 1988). (iii) p4a (gene AI0L)
and (iv)~ (gene A3L) are also proteolytically processed (Katz and Moss, 1970; Rosel and
Moss, 1985; Sarov and Joklik, 1972; vanMeir and Wittek, 1988; VanSlyke et al., 1991;
Vanslyke and Hruby, 1994; VanSlyke and Hruby, 1990; Wittek et al., 1984). p4a (105kD) is
cleaved to yield a 68kD protein, 4a, while p4b (74kD) is cleaved to the resultant 4b (62kD).
These two proteins are additionally modified by ADP-ribosylation (Child et al., 1988). The
post-translational cleavage of p28, p4a and p4b is prevented by addition of the drug,
rifampicin (see section 1.5) (Katz and Moss, 1970). (v) The product of the gene 17L is
another structural protein of the core. A virus, ts16, which has a temperature sensitive
mutation in this protein does not assemble IVs (Condit et al., 1983; Ericsson et al., 1995;
Kane, 1993). (vi) ~ (DI3L), the target of the drug rifampicin (discussed in section 1.5)
(Baldick and Moss, 1987; Moss et al., 1971; Nagayama et al., 1970; Tartaglia and Paoletti,
1985; Tartaglia et al., 1986), has been localized to the concave surface of the IVs and is
thought to playa role in the development and rigidity of these intermediate compartment
derived membranes (Sodeik et al., 1994). (vii) RJ2 (gene A4L) is a highly immunogenic
core protein which is synthesized at late times during infection (Demkowicz et al., 1992;
Maa and Esteban, 1987; Paez et al., 1987). This protein is the focus of chapter 2 of this
thesis.
1.4.2 Membrane proteins of the IMY
To date, six proteins have been described as components of the IMV membranes. (i)
p 14 (gene A27L) was identified when monoclonal antibodies against a 14kD protein were
shown to neutralise IMV infectivity, indicating that p14 may playa role in virus penetration
(Rodriguez and Esteban, 1987; Rodriguez et al., 1985). It was later confirmed that p14 is
involved in fusion of the viral envelope with the cell plasma membrane (Doms et al., 1990;
Rodriguez et al., 1987) and is also involved in cell-cell fusion late in infection (Gong et al.,
1990; Rodriguez et al., 1985; Rodriguez et al., 1987). p14 can form trimers which are
covalently linked by disulphide bonds (Rodriguez et al., 1987). P14 does not seem to be
--
essential for the infectivity of the n:2 but rather for wrapping of the IMV by the TON due
to interactions with another vaccini membrane protein, p37 (F13L) (see sections 1.4.3 and
1.5), which is targetted to the TGN membranes*(Rodriguez and Smith, 1990).
Immunoprecipitation with antibodies to p14 identified another membrane protein of the
IMV, (il) p21 (AI7L) (Rodriguez et al., 1993; Rodriguez and Esteban, 1987). p21 is a
quadruple spanning membrane protein which is present in the inner of the two membranes
9
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surrounding the IMV (Krijnse Locker et al., submitted) and which may act to anchor p14 in
the membrane as p14 does not have a membrane spanning domain. (iii) M25 (LIR) is a
25kD protein which is covalently modified by the addition of the C14 fatty acid, myristate
(Franke et al., 1989; Franke et al., 1990). The signal which localizes this protein to the IMV
membranes apPears to reside in both the fatty acid moiety and the first 12 N-terminal amino
acids (Franke et al., 1989; Ravanello and Hruby, 1994; Ravanello et al., 1992). (iv) p32
(D8R) has a C-terminal membrane spanning domain and was shown to be non-essential for
virus propagation in tissue culture (Niles and Seto, 1988; Rodriguez et al., 1992). It is
thought that p32 facilitates the binding of IMV to the plasma membrane during infection
(Lai et al., 1991; Maa et al., 1990). (v) There has been some discrepancy over the identity of
a 35kD component of the IMV membranes. It was originally identified as the gene product
of H6R, an early gene (Gordon et al., 1988; Gordon et al., 1991; Wilton et al., 1986), but was
later attributed to the late gene H3L (Zinov'ev et al., 1992). (vi) The surface of the IMV has
been shown to be covered with protrusions called surface tubular elements (STE). These
STEs are composed of a 58kD protein that elicits an antibody which can suppress vaccinia
infectivity and cell-cell fusion (Stem and Dales, 1976). More recently, the core protein 4b
(gene A3L, see section 1.4.1) was also identified as a component of these STEs (Wilton et
al., 1995).
1.4.3 Membrane proteins of the EEV
In its additional TGN-derived outer membrane, the EEV has a number of extra
virally-encoded membrane proteins, of which five have been identified (Hiller and Weber,
1985; Payne, 1979; Payne, 1978). (i) HA or haemagglutinin has been sequenced in four
different strains of vaccinia; gene salGIR in vaccinia strain WR (Smith et al., 1991); gene
A56R in COPenhagen (Goebel et al., 1990); IHD-J (Shida, 1986) and Tian Tan (Jin et al.,
1989). It has an apparent molecular weight of 89kD and is found on both the pfa,,..a
1MAlb"~of infected cells and in the outer membrane of the EEV. HA is a type I integral
membrane protein which shows sequence homology to the immunoglobulin (Ig) sUPerfamily
(Jin et al., 1989; Shida, 1986). HA is thought to playa role in EEV adsorption to the cell
surface, and prevents polykariocytosis of infected cells (Ichihashi and Dales, 1971; Payne
and Norrby, 1976). It is a non-essential protein as vaccinia strains which are HA-(IHD-W)
are infectious. It is glycosylated with both N- and o-linked carbohydrates (Shida and Dales,
1981). (ii) The major, and until recently the only recognised nonglycosylated protein of the
EEV membrane, p37 (gene FI3L), has already been mentioned due to its role during
wrapping of the IMV by a cisterna from the TGN (section 1.4.2) (Hiller and Weber, 1985;
Payne, 1992). p37 contains bound palmitate and oleate which are thought to facilitate its
binding to the viral membrane (Hiller and Weber, 1985; Payne, 1992; Schmutz et al., 1991).
p37 is the only protein thus identified which is cytoplasmically exposed on the outside of the
10
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lEV (Schmutz et al., 1995). As will be discusssed in more detail, deletion of p37 prevents
wrapping of the IMV (section 1.6) (Blasco and Moss, 1991; Blasco and Moss, 1992) and a
mutation in the gene encoding p37 confers resistance to the drug, IMCBH (see also section
1.6) (Schmutz et al., 1991). (iii) gp42 (gene B5R in vaccinia strain WR (Smith et al., 1991),
Copenhagen (Goebel et al., 1990), Lister (Takahashi-Nishimaki et al., 1991) is another
acylated EEV glycoprotein. It is a type I integral membrane protein with homology to
complement control factors, . . gp42 is very
conserved among the vaccinia strains within which it has been identified to date; cowpox
virus, rabbitpox virus, and seven different vaccinia strains (WR, Lister, Copenhagen,
TianTan, Wyeth, Tashkent and IHD-W) (Engelstad et al., 1992) and is also thought to
participate in the envelopment of IMV by TGN membranes (Engelstad and Smith, 1993;
Wolffe et al., 1993). (iv) gp21 (salL4R in WR and A34R in Copenhagen) is a
phosphorylated, sulphated, palmitoylated glycoprotein (Payne, 1992). This protein displays
homology to C-type animallectins (Duncan and Smith, 1992) and the lectin domain of this
glycoprotein is thought to be involved in the retention of CEV at the plasma membrane in
the WR strain (Blasco et al., 1993). (v) A36R encodes a 43-50kD type n integral membrane
protein of the EEV. It is a 221 amino acid protein with a N-terminal hydrophobic sequence
and seven potential sites for attachment of N-linked carbohydrate, but despite this does not
appear to be N-glycosylated. p43-50 does not playa role in binding of the EEV to the cell
surface during virus entry, but is required for the formation of normal levels of EEV
(Parkinson and Smith, 1994).
1.5 Drugs which inhibit the vaccinia life cycle
There are a number of different drugs which block the life cycle of vaccinia virus at
various stages. For many of these drugs, inhibitor resistant mutants have been isolated
which have given valuable insights into vaccinia assembly and especially functional
information on the mutant protein in question. Those inhibitors which have been used
during the course of this research will be described here, while the stage at which they
prevent viral assembly is shown in figure 3. Hydroxyurea (HU) can be used to reversibly
block vaccinia DNA replication and therefore prevents intermediate and late gene
expression. For this reason it has been traditionally used to synchronize DNA replication
and viral assembly (Morgan, 1976; Pogo and Dales, 1971; Rosenkranz et al., 1966). It also
provides a means to identify the temporal class of gene encoding a particular protein, as
intermediate and late genes are not expressed in the presence of this drug. Rifampicin (Rif),
a macrolide antibiotic, specifically blocks vaccinia assembly from proceeding past the viral
factory stage (Moss et al., 1969). Rif resistant mutants allowed the identification of the gene
.responsible for the sensitivity to this drug, D13L, which encodes a 65 kD protein (Baldick
11
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and Moss, 1987; Nagayama et al., 1970; Tartaglia and Paoletti, 1985; Tartaglia et al., 1986).
Rif prevents P65 from being targeted to the membranes surrounding the viral factories, and
hence the "crescents" fail to develop and viral assembly is blocked. The effects of this drug
are also reversible, with normal viral assembly continuing after washout. Rif does not block
viral protein synthesis (but does prevent cleavage of the core proteins p4a, p4b and p28, see
section 1.4.1) and thus acts as an ideal way to prevent virus formation at a stage subsequent
to viral structural protein synthesis. Rifampicin was used in chapter 2 of this study to
prevent virus assembly, as viral proteins are more accessible to biochemical analysis in the
absence of virion formation. IMCBH, or N l-isonicotinoyl-N2-3-methyl-4-chlorobenzoyl-
hydrazine, prevents wrapping of the IMV by membranes from the TGN thus blocking
assembly of the lEV (Hiller et al., 1981; Kato et al., 1969; Payne and Kristensson, 1979).
The target of this drug was identified as being the 37kD protein (gene F13L) of the lEV
(section 1.4.2) (Hiller et al., 1981; Schmutz et al., 1991). During normal virion assembly
this protein is targeted to the membranes of the TGN where it is thought to interact with the
14kD peripheral protein which is exposed on the outer surface of the IMV, thus initiating
IMV wrapping by TGN cisternae '-': (sections 1.4.2 and 1.4.3).
IMCBH was used in chapter 3 to prevent lEV formation.
DNA core
RNA polymerase
poIy(A) polym_
capping enzyme
methYlating enzvrn-
EEV
morphogeneeia 4 - 20h
FIGURE 3: A scheme of the vaccinia life cycle showing the stages at which the various drugs block the
assembly process.
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1.6 Vaccinia assembly mutants
There are many different mutants of vaccinia assembly which have greatly facilitated
the understanding of the vaccinia lifecycle. Three different mutants have been used in the
present study. vRB12 and vRBI0 are both deletion mutants in which the gene encoding the
37kD protein of the lEV, (gene FI3L), has been deleted in WR and DID-J respectively
(Blasco and Moss, 1991; Blasco and Moss, 1992). Therefore these mutant viruses are unable
to wrap with membranes from the TON and consequently do not form lEV.
Vaccinia virus encodes a protein which is 31 % identical to cellular profilin (Blasco et
al., 1991). In chapter 3, I used a deletion mutant in which the A42R gene, which encodes
vaccinia profilin, was deleted. All of these mutants were generous gifts of Dr. Rafael
Blasco, Madrid, Spain.
1.7 Interactions of intraceUular pathogens with the actin cytoskeleton
A number of different pathogenic bacteria have been shown to utilize the host cell
actin cytoskeleton in order move within the cell and from one cell to another. This system
can provide insight into the mechanism by which local actin polymerization is controlled in
cells, in the absence of complex plasma membrane mediated cellular signalling processes.
The fIrSt bacterium discovered to move in this manner was Shigella flexneri, a gram
negative, enteroinvasive bacterium which causes bacillary dissentry (Adam et al., 1995;
Bernardini et al., 1989; Goldberg and Sansonetti, 1993; Ogawa et al., 1968; Vasselon et al.,
1991). Other obligate intracellular bacteria capable of actin-based intra- and
intercellular motility include Usteria ivanovii, which is pathogenic exclusively for animals,
causing abortions, neonatal sepsis and enteritis (Karunasagar et al., 1993) and Rickensia
conorii, along with Rickensia rickensii, which cause serious diseases in humans such as
Mediterranean spotted fever and Rocky Mountain spotted fever respectively (Heinzen et al.,
1993; Teysseire et al., 1992). Another bacterium which moves in this manner is Usteria
monocytogenes, and, as it has been the most thoroughly studied in respect to its actin-based
motility, it will be described below in more detail.
Listeria monocytogenes is a ubiquitous, rapidly growing, gram positive bacterium
which is responsible for severe food borne infections which can cause meningitis,
encephalitis and septicemia causing a high mortality rate in newborns, elderly and
immunocompromised persons (Gellin and Broome, 1989). Electron microscopy studies
have shown the life cycle of1. monocytogenes, in respect to its associations with actin at
CI
different stages of infection (Tilneyet al., 1990; Tilney et al., 1992; Tilney et al., 1992~)
Tilney and Portnoy, 1989). A cartoon depicting the life cycle ofUsteria is shown in figure
13
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Introduction
These actin tails are the means by which the bacterium moves within the host cell.
They are composed of apparently short, O.2f.1m actin filaments which are oriented
unidirectionally with their barbed, or fast growing, ends towards the bacterium (Tilney et al.,
1992) 3. Fluorescence polarization ratio images show that the filament organization in outer
shell of the actin tail appears to be parallel while the fl1aments in the core of the tail are more
disordered (Zhukarev et al., 1995). Video microscopy of infected cells which were
microinjected with fluorescently labelled G-actin indicated that actin nucleation and filament
elongation occur close to the bacterial surface (Sanger et al., 1992). The elongation of the
comets is caused by the addition of actin monomers to the barbed end of the filaments, which
are present at the bacterial surface. This actin tail formation induces bacterial movement
which can be very rapid, up to 1.46f.1m1sec, but the range of listeria motility rates varies
from one cell type to another (Dabiri et al., 1990; Nanavati et al., 1994). There is a positive
correlation between the rate of actin polymerization and bacterial movement, with the faster
moving bacteria having longer tails (Theriot et al., 1992). Comet length is dependant on the
rate of actin polymerization at the bacterial end of the tail, which occurs at varying rates. In
contrast, depolymerization occurs at a constant rate and throughout the length of the tail
(Nanavati et al., 1994).
Cells contain a plethora of special actin binding proteins (ABP) which playa role in
facilitating both the polymerization and depolymerization of fl1aments (for reviews see
(Hartwig and Kwiatkowski, 1991; Pollard and Cooper, 1986; Stossel et al., 1985). Actin
binding proteins can be subdivided into different classes based on their functions (figure 5),
such as bundling of actin filaments (e.g. alpha actinin and fimbrin), cross-linking (e.g.
filamin), severing (e.g. gelsolin), sequestering (e.g. pthymosin and profl1in), capping (e.g.
cap Z) and motor proteins (e.g. myosins). Many of these actin-binding proteins have been
found associated along the length of the bacterial comets and are presumed to playa role
in the dynamic stability of the actin tails. These include alpha actinin which is crucial for tail
formation (Dold et al., 1994; Nanavati et al., 1994), fl1amin (Dabiri et al., 1990) and fimbrin
(Temm-Grove et al., 1994). Also present are vinculin, which is normally found at focal
adhesion sites, talin (Dold et al., 1994), and ezrin-radixin (Temm-Grove et al., 1994).
Tropomyosin is found along the length of the tails and may act to protect the fl1aments
(oabiri do. ~ r;'0). Villin, which is normally limited to microvilli in vertebrate epithelial
cells, was also found in the bacterial tails (Temm-Grove et al., 1994). Profilin is
concentrated at the site of actin filament formation, rather than being incorporated into the
tails, and was initially shown to be essential for bacterial movement (Theriot et al., 1994).
3 Due to the harsh extraction techniques used in this study, this filament length is most likely an
underestimation of the true filament length. There is evidence that the filaments are longer than this, reaching
lengths of over O.5J.L1Il (Dr.s Peg Sievert and Tim Mitehison, personal communication).
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FIGURE 5: Some of the major classes of actin binding proteins found in most vertebrate cells. Actin is shown
in red, while the actin binding proteins are in green. From. (Alberts et al., 1994)
More recently, however, profilin has been shown not to be strictly necessary for Listeria
movement, but when present participates in actin assembly and may even stimulate this
process (Marchand et al., 1995). There is no indication that any myosin is present in the
tails, further supporting the hypothesis that actin polymerization itself produces the force to
generate motility.
These motile bacteria also encode virulence genes which are required for the actin-
based motility. This became apparent when it was discovered that mutants defective in the
act A gene could not form actin tails and hence bacterial spread was abolished (Domann et
al., 1992; Kocks et al., 1992). The 90kD Act A protein (figure 6) is located on the outer
surface of the bacterium, anchored to the bacterial membrane by a hydrophobic C-terminal
sequence (Domann et al., 1992; Kocks et al., 1992; Vasquez-Boland et al., 1992). The
distribution of Act A is polarised and this is thought to arise when the bacteria divide as the
membrane which forms at the site of septation is devoid of Act A, with the protein being
concentrated at the opposite "older" pole of the cell (Kocks et al., 1993). This is thought to
16
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be the determining factor which causes Listeria movement in one direction, that is, in the
direction of the non-Act A expressing pole. Act A has four polyproline repeats in the middle
of the sequence which are not essential for actin motility (Pistor et al., 1995). Initially
postulated as a possible profilin binding site due to the high affinity of profilin for
polyproline (perelroizen et al., 1994), these polyproline repeats were later shown not to bind
profilin (Marchand et al., 1995) but are responsible for binding to VASP (vasodilator-
stimulated phosphoprotein, discussed later). The N-terminal part of Act A (amino acids 128-
151) is required for actin assembly (pistor 1995, Friedrich 1995). When the protein was
transiently expressed in uninfected cells, it was targetted to the host cell mitochondria, but
the mitochondria remained immobile (pistor et al., 1994). A 130kD protein, Ics A, which
has a similar function, but no homology, to Act A was previously identified in Shigella
flexneri (Bernardini et al., 1989; Lett et al., 1989). Unlike Act A, it is present throughout
the comets of moving Shigella, as well as on the outer bacterial membrane (Goldberg and
Sansonetti, 1993). The virulence gene necessary for actin-assembly in 1. ivanovii, iact A,
has also been identified and this protein shows low homology to Act A (Gouin et al., 1994).
1 29 128 151 265 390 513 518 813 830
• N-termiml bacterial singal sequence
• F actin recruitment site
• Polyproline repeats - bind VASP
• LPATKmotif typical of cell wall preteins ofGram-p:>Sitive bacteria
• C-termiml anchor region
FIGURE 6: Schematic representation of the Act A protein
Although required for actin assembly and profilin concentration at the pole of the
bacterium, Act A does not bind directly to either protein. This together with the finding that
Listeria grown in broth will not induce the assembly of actin comets (Tilney et al., 1992).
indicates that the presence of host proteins is probably necessary for motility. The
development of a cell-free system of concentrated Xenopus egg extracts, in which Listeria
movements can be reproduced has made biochemical analysis of these cellular factors
possible (Theriot et al., 1994).
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One candidate cellular component is vasodilator-stimulated phosphoprotein (VASP),
a highly abundant substrate of both cAMP- and cGMP-dependant protein kinases which co-
localises with actin fllaments in focal contacts, stress fibres and membrane ruffles (Haffner et
al., 1995; Reinhard et al., 1992). VASP, a 40kD protein, has three distinct phosphorylation
sites and is also rich in proline residues which are concentrated in the central region of the
protein (Haffner et al., 1995). It was shown that profilin can bind to the polyproline regions
of VASP, thereby identifying VASP as the frrst endogenous proline-rich ligand of profilin
(Reinhard et al., 1992). Subsequently it was shown that VASP accumulates on the surface of
Listeria in a polarised fashion, prior to the detection of the actin clouds but it is not
incorporated into the actin tails (Chakraborty et al., 1995). VASP can bind directly to Act A
polyproline repeats, and therefore provides the first physical connection between a bacterial
protein and the cytoskeleton (Pistor et al., 1995). VASP also associates with the actin tails of
Shigella, being incorporated evenly along the complete length of the actin tail, as is Ics A.
However an overlay blot with radiolabelled VASP indicated that it does not interact directly
with Ics A (Chakraborty et al., 1995).
Now that three major proteins involved in the process of Listeria actin-based motility
have been identified, Act A, profilin and VASP, it is possible to hypothesize as to how these
bacteria co-opt the actin cytoskeleton of the host cell. Three possible models for actin
recruitment and tail elongation at the pole of Listeria are shown in figure 7. Profilin is
thought to playa role in delivering the actin monomers to the growing ends of the filaments,
but more direct evidence will be needed to establish the complete mechanism.
1.8 Viruses and the actin-cytoskeleton
Many reports have indicated that viroses can associate with the actin cytoskeleton. In
the mid 19708 a 42 kD protein identified as cellular actin, was found to be present in the
virions of many enveloped viruses, such as Sendai virus (Lamb et al., 1976), a number of
different mammalian RNA tumour viruses (Wang et al., 1976), murine mammary tumour
virus (Damsky et al., 1977), measles virus (Wechsler and Fields, 1978) and rabies virus
(Naito and Matsumoto, 1978). The M protein of paramyxoviruses was also shown to
interact with cellular actin (Giuffre et al., 1982). Later studies with cytochalasin B, a drug
which inhibits actin polymeritation, prevented the release of infectious measles virus in a
manner that was not related to a defect in glycosylation (as cytochalasin B also affects
protein glycosylation) (Stallcup et al., 1983). It was later suggested that actin filaments are
involved in the formation of viral buds at the plasma membrane, as actin fllarnents were
observed to protrude into measles particles, which were in the process of budding from the
plasma membrane, with the barbed ends of the fllaments in close association with the
18
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showed, using high voltage electron microscopy, that the migration of vaccinia virions from
factories to the plasma membrane of infected cells involved an association with the host cell
cytoplasmic network. He also demonstrated the presence of specialized microvilli with virus
particles at the tip (Stokes, 1976). A few years later it was demonstrated that the filaments in
question in Stokes' report were actin-containing microftlaments (Hiller et al., 1979). The
specialised microvilli, conspicuously absent from uninfected cells, were characterized and
shown to be variable in length (1.8-3.0 J.1IIl), with a constant diameter (0.30-0.35 J.lm), much
larger than that of normal microvilli. Antibodies to myosin and tropomyosin failed to label
these microvilli, but alpha-actinin, filamin and fimbrin were identified (Hiller et al., 1981;
Hiller et al., 1979). Studies with drugs which arrest vaccinia assembly, such as sodium
fluoride, cycloheximide, and actinomycin D, showed that virus particle formation is
necessary to induce microvilli production (Krempien et al., 1981).
The intimate relationship between the actin cytoskeleton and vaccinia virus at the
various stages of its life cycle, suggests the vaccinia may contain proteins which interact
with actin. One possible candidate protein is the gene product of A42R that displays 31%
identity to cellular proftlin (Blasco et al., 1991). This viral profilin is a 15kD protein which
is synthesized at late times during infection. Deletion of A42R showed that it is not required
for infectivity or release of mature virions. Immunofluoresence studies with an antibody
directed against A42R showed no evident association of vaccinia proftlin with actin
ftlaments. This vaccinia profilin differs from its cellular counterparts in that it has a higher
affinity for phosphoinositides than for actin or polyproline, suggesting that it may rather play
a role in cellular signalling (Machesky et al., 1994).
1.10 Thesis Aims
During the initial stages of my thesis, I set out to characterize the proteins in the virus
which may playa role during the transition of the IV to the IMV. As one of the changes
which occurs during this maturation step is a major shape rearrangement from a spherical IV
to a parallelepiped or "brick" -shaped IMV, I began with the identification of the membrane
proteins in the IMV, assuming that they playa structural role in this shape transition.
Vaccinia membranes were separated from the viral cores using a combination of 1% NP 40
and 20mM DTT, a classical method used for this purpose (Easterbrook, 1966; Essani and
Dales, 1979; Holowczak and Joklik, 1967; Oie and Ichihashi, 1981; Samv and Joklik, 1972).
The resultant sample was centrifuged through a 36% sucrose cushion, whereby the cores
pelleted, while the viral membranes remained on top of the cushion. The membrane proteins
were subsequently identified by peptide sequencing. After this NP 40 I DTT treatment, there
20
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was one protein which behaved in an unusual manner in that it was present in both the
membrane and core fractions, in variable proportions. Therefore I investigated this protein
further, as due to its presence in both the membrane and core fractions, it was plausible that
it could act as a possible link between the core and the surrounding membranes of the IMV.
This protein is p39, gene A4L, and is the subject of chapter 2.
Nothing was known about how vaccinia moves in the cell or even if the associations
between the virus and actin which have been reported (Hiller et al., 1981; Hiller et al., 1979;
Krempien et al., 1981; Stokes, 1976) are sufficient to actually support viral movement.
Therefore, during the later part of my thesis research, I examined the subject of both inter-
and intracellular motility of vaccinia virus more thoroughly. I demonstrated that vaccinia-
virus can co-opt the actin cytoskeleton of the host cell, in a manner not unlike Listeria, in
order to move both within the cell and from one cell to another, in order to cause direct cell-
to-cell spread of the disease. This work is presented in chapters 3 and 4.
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Chapter 2
ABBREVIAnONS
IV Immature virus
IMV Intracellular mature virus
p.i. post-infection
NP 40 Nonidet P 40
DIT Dithiothreitol
TX-114 Triton X-114
Rif Rifampicin
PBS Phosphate buffered saline
PNS Post nuclear sUPernatant
MEM Minimal essential medium
Na2C03 Sodium carbonate
ABSTRACT
We describe the characterization of the product of the A4L gene of vaccinia virus,
p39. Using immunolabelling of thawed cryosections from infected HeLa cells, we
show that this protein is initially located in the central region, or "viroplasm", of the
viral factories, as well as the immature virions (IV), with very low amounts of
labelling observed on the surrounding membranes. The localization of p39 changes
dramatically during the transition of the IV to the intracellular mature virus (IMV),
coincident with the apPearance of the core structure in the centre of the IMV, and it is
now located between this core and the surrounding membranes. Complanentary
biochemical data, such as partitioning into Triton X-114 detergent phase and stripping
of the viral membranes with Nonidet P 40 and dithiotfeitol, suggest that p39 is
strongly associated with the inner of the two membranes surrounding the core.
Sodium carbonate treatment also indicates that p39 is associated with membranes,
even at the early stages of viral assembly. However, following in vitro translation of
p39 in the presence of microsomal membranes we failed to detect any membrane
association of the indePendently expressed protein. We also failed to detect any post-
translational acylation of p39 with myristate or palmitate, suggesting that p39 does not
achieve its membrane association through lipid anchors. Therefore, p39 is most likely
membrane-associated through an interaction with integral membrane protein(s)
present in the inner of the two membranes surrounding the IMV. Together with our
recent data showing that p39 co-localizes with the spike-like protrusions on the IMV
core (47)(Roos et al., (1996) EMBO J., in press), we suggest that p39 may form part
of this spike and possibly functions as matrix-like linker protein between the core and
the inner of the two membranes surrounding the IMV.
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INTRODUCTION
Vaccinia virus, the prototype member of the Poxviridae, has a 190kb dsDNA genome
which has been completely sequenced (17, 24). This genome codes for 263 potential
open reading frames, of which approximately 100 proteins are associated with the
virus particle (12). The transcription and translation of these genes can be divided
into three temporal classes; early, intermediate and late (36, 41). The early genes are
those which are transcribed prior to DNA replication, while the intermediate and late
genes are only transcribed after the viral genome has been replicated. The vaccinia
structural proteins are normally encoded by the late proteins (36).
Vaccinia virus assembly has been extensively studied by electron microscopy but little
is known about the molecular events which take place during the assembly process.
The fmt morphological evidence of the infection process is the appearance of large
structures enriched in DNA (2, 20, 25) at about 1-2 hours post infection. These
structures, which are also visible by light microscopy, referred to as "viral factories",
are thought to be the site of viral DNA replication and transcription (2, 36, 37). The
fmt sign of viral membrane assembly is the appearance of rigid, curved membrane
structures referred to as "crescents", which appear to bud in the region of the viral
factories. Once thought to be the only example of de novo membrane synthesis (5,6,
59), it now appears that the first membranes of vaccinia are derived from a
cisterna of the intermediate compartment between the rough endoplasmic reticulum
and the Golgi complex (28, 53). These crescents, which are the progenitors of the
immature virion (IV), normally appear as one membrane profile in electron
micrographs but have been shown to consist of two tightly apposed membrane
bilayers (53). The spherical shaPed IV, after the packaging of the viral genome and
cleavage of some of the core proteins (26, 27, 39, 49, 56, 57), develops a core
structure surrounding the DNA and matures into the brick-shaped intracellular mature
virus (lMV), the fmt of two distinct infectious forms.
There is a marked difference between the stIUcture of the IV and the IMV. The IMV
has two "membrane-like" profiles when viewed by both conventional thin sectioning
and cryo electron microscopy, the innermost of these representing the newly formed
core stIUcture, while the outer profile is qualitatively the same as the two membranes
surrounding the IV, i.e. it represents the two tightly apposed membranes derived from
the intermediate compartment (47, 53). While the central region of the IV clearly
consists of electron-dense material that can be labelled with antibodies to vaccinia
core proteins (11, 54, 58), it has not yet packaged the DNA and does not contain the
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final internal core-structure (see e.g. (11). Nothing is known about either the origin or
the composition of the inner "membrane-like" structure surrounding the DNA or how
it is formed during the transition from IV to IMV. A possible explanation for the
sudden appearance of the core during the assembly process may be that the insertion
of the DNA into the IV (see (35), which coincides with the proteolytic cleavage of
some of the major core proteins (26, 27, 39, 56, 57, 60), may lead to a rearrangement
of these core proteins to form the core structure. Following this process, the IMV
membranes appear brick-shaped, rather than spherical as they were in the IV. This
change in shape is possibly caused by an interaction of one or several inner membrane
protein(s) with components on the surface of the newly formed core.
In pioneering electron microscopic studies ofIMV particles, Dales (1963) clearly
showed the presence of spike-like protrusions extending between the core and the
surrounding membranes, using a combination of thin sectioning and negative staining.
In a more recent study, Dubochet et al. (1994) performed cryoelectron microscopy, a
method that does not involve chemical fixation, dehydration or embedding techniques,
on intact IMV as well as isolated vaccinia cores. Isolated cores are operationally
defined as the particle which remains intact after treatment of IMV with Nonidet P-40
and a reducing agent such as dithiotreitol or p-mercaptoethanol (10,43,55). In these
later studies, the spikes were clearly visualized on the outer surface of the isolated
cores, as well as in untreated IMV. These data were extended by combining
cryoelectron microscopy with immunogold labelling of antigens on the surface of the
core (47), which suggested that these spike-like protrusions may be composed ofp39,
the focus of this paper.
p39 was first identified by Maa and Esteban (1987) as a highly antigenic protein that
produced a strong immune response in mice and rabbits. They demonstrated that p39,
a product of the late class of genes, is an acidic polypeptide which is present in the
core. The protein was later identified as the product of the A4L gene and it was
established that the C-terminal 103 amino acids were the most immunogenic region of
the protein, eliciting an antibody response in vaccinated humans which persists for
years (7). Due to both its location on the outside of the core and its abundance in
virions, we suspected that p39 might play an important role during the transition of the
IV to the IMV. We therefore attempted to establish a function for p39 during virion
assembly and maturation. We propose that p39 plays a matrix-like role in the viri~
acting as a link between the core and the surrounding membranes in the IMV.
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MATERIALS AND METHODS
Cells, virus and antibodies: HeLa cells were grown and infected with vaccinia virus
strain WR as previously described (53). Two different antibodies were used in the
present study. First, we used the rabbit antiserum raised against p39 previously
described by Demkowicz et ale (1992), a kind gift from M. Esteban. In addition, we
made a new rabbit polyclonal. A Peptide representing the C-terminal residues 267-
281 of the protein product of gene A4L was synthesised (pI of 10.78), and was
solubilized in PBS prior to covalent coupling to keyhole limPet hemocyanin. Rabbits
were immunized in the popliteal lymph node on day 1 with 200J.1g of Peptide in
Freund's complete adjuvant (Sigma). They received subscapular boosts of 50J.1g
Peptide in Freund's incomplete adjuvant (Sigma) on days 21 and 42 and 50ml bleeds
were taken 10 days after each boost On day 63 the rabbits received an intramuscular
boost of 25J.1g of Peptide in phosphate-buffered saline (PBS) followed on 2
consecutive days by intravenous boosts of 25J.1g. Ten days later the animals were
sacrificed and serum prepared. Western blot analysis showed that this Peptide
antibody recognised p39.
MetaboUc labeBing of virus and infected cells: Four 175 cm2 flasks of subconfluent
HeLa cells were infected at a MOl of 10. Two mCi of 3SS Express Methionine
Cysteine (Du Pont, NEN, Boston, MA) in 20 mls of labelling medium (10% MEM
containing 5% FCS; 90% methionine and cysteine free DMEM; Sigma) was added to
the infected cells at 6 hours post-infection. After 24 hours of infection, the radioactive
label was chased for 2 hours by replacing the labelling medium with MEM containing
5% FCS. The virus was purified using a 36% sucrose cushion, followed by a 15-40%
sucrose gradient in a SW40 rotor (8). 3sS-labelled post-nuclear sUPernatant from
infected cells was prepared as follows. HeLa cells were infected as above and
incubated in MEMlFCS containing lOOJ.1g1ml of rifampicin (Sigma). The cells were
labelled with 4OJ.1Cilml of 3SSExpress from 6 to 8 hours post-infection in labelling
medium and chased for one hour, still in the presence of rifampicin. Cells were then
scraped from the dish in PBS-Ca-, gently Pelleted and resusPended in 10mM Tris-CI,
pH 9. The cells were broken by 10 to 12 strokes of a dounce homogenizer and the
nuclei removed by centrifugation at 3000rpm for 10 mins. For the pulse-chase
analysis, infected cells were pulse-labelled at 7 hours post-infection (pj.) for 5
minutes with 1OOJ.1Cilml 3SSExpress and subsequently chased for the indicated times.
The labelled cells were lysed as described (29), the lysates concentrated by acetone
precipitation at -200c and the precipitate dissolved in ftrSt dimension lysis buffer
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(9.8M urea, 2% ampholines (Pharmacia, Uppsala, Sweden), pH 7-9, 4% NP-4O and
l00mMDTI).
For preparation of PNS labelled with either 3H-myristate or 3H-palmitate
(250JlCilml of each) (13), the labelled lipids were added to infected cells, in D-MEM
with 2% delipidated FCS, at 4h after infection.. PNS was prepared at 24h p.i., as
described above. For 32p-Iabelled PNS, infected cells were starved of phosphate for
30 minutes (in D-MEM without Na2P04 containing 2% dialysed FCS) prior to adding
400JlCi of 32p at 6h p.i.. The labelled cells were harvested at 24h p.i. and a PNS
prepared as described above. 3H-glucosamine labelling was carried out in RPMI
medium (glucose free) containing 2% dialysed FCS, 2mM glutamine and 1{}J.1g/ml
glucose. 75mCilml of 3H-gJucosamine was added to a 3cm dish of cells at 4h p.i. and
PNS was prepared at 24h p.i.. Immunoprecipitation with antibodies to p39 (7) or p21
(AI7L) (28) was carried out as previously described (29) followed by analysis on 15%
SDS-PAGE.
Protein microsequencing: Purified IMV was resolved on a 15% SDS-PAGE. After
electrophoresis the gel was stained with Coomassie Brillant Blue (R250) and a band,
which comigrated with p39 on western blots was excised. The gel piece was
subjected to tryptic digestion, the peptides separated by HPLC and two resulting
Peptides were sequenced using Edman automated degradation (30). The two 7 amino
acid sequences were used to search for homologies in the Swissprot data bank using
Blitz, Brookhaven data bank, PIR and Swissprot using Blast, and Genbank and the
EMBL Data Library using TFasta. These peptides are identical to amino acids 42-50
and 59-66 of the vaccinia WR strain A4L gene (AC P29191).
Immunofluorescence microscopy: Cells grown on coverslips were infected as
described above and, following 3 washes in PBS, were fIXed at 8h p.i. with 3%
paraformaldehyde in CB (10mM MES, 150mM NaCI, 5mM EGTA, 5mM MgC12,
5mM glucose, pH 6.1) for 10 minutes at room temperature. Following 3 washes in
CB, cells were permeabilised with 0.1% TX-lOO for 60 seconds and then blocked with
1% FCS and 1% BSA for 10 minutes. The infected cells were labelled with the
antiserum against the C-terminus of p39 (diluted 1: 3(0) for 30 minutes and
subsequently incubated with FITC-conjugated goat anti-rabbit antibody (Dianova-
immunotech GmBH, Germany) together with 5Jlg/ml Hoechst (No. 33258, Sigma) for
30 minutes. The coverslips were washed 3 times in CB, rinsed in distilled water and
mounted on slides in moviol. The samples were examined with a Zeiss axiophot
microscope.
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Electron microscopy: For negatively stained samples, IMV was adsorbed to a glow-
discharged, formvar- and carbon coated EM grid for 2 minutes. The sample on the
grid was subsequently treated with either 1% NP-40 or 20mM DTI or both, for 30
minutes at 37°C. The IMV absorbed to the grid was also treated with either 50flglml
proteinase K for 30 minutes on ice or 50J.1g1ml trypsin for 30 minutes at 37°C.
Following 3 washes in 10mM Tris pH 9, the grids were incubated with 10% fetal calf
serum in PBS and subsequently with primary antibody (p39 antiserum or a
monoclonal antibody against p14 (mAbC3, 46) both from M. Esteban) diluted in 5%
FCS-PBS for 15 minutes. In the case ofp14 the labelling was followed by incubation
with a rabbit anti-mouse antibody (Cappel, USA). Subsequently the grids were
incubated for 15 minutes with 100m protein-A gold and then briefly washed in triple
distilled water before staining with 1.5% uranyl acetate for 60 seconds (52).
Cells which were infected for 8 h, and cells which were infected in the
presence of rifampicin for 16 h, were fIXed and prepared for cryo sectioning as
previously described (18, 54). Purified IMV were prepared by pelleting at 14,OOOrpm
in an eppendorf centrifuge and were then fixed with 4% paraformaldehyde and 0.1%
glutareldehyde for 30 minutes. The pellet was subsequently inftltrated with 2.1M
sucrose for 15 mins and rapidly frozen in liquid nitrogen. Immunolabelling of frozen
hydrated cryosections was performed as previously described (48, 52, 53).
Protease treatment: Purified IMV was incubated on ice for 30 minutes with
proteinase K (Merck, Darmstadt, Germany) at 5, 10,20,30,50, 100,200 and 300
flglml in 10mM Tris pH9.0 (made from a Imglml stock solution in isopropanol,
stored at -80°C). Reactions were stopped by the addition of PMSF
(polymethylsulphonylfluoride; stock 10mM in isopropanol, stored at -20°C,Sigma) to
a fmal concentration of 1mM. Purified virus was also treated with 50J.1g1ml of Q-
chymotrypsin (TLCK treated; Sigma; stock solution Imglml, stored at -20°C),
l00flglml of thermolysin (Boehringer, Mannheim; stock solution IOmglml in 20mM
CaCI2, stored at -20°C,) and 250J.1g1ml V8 (endoproteinase Glu-C, Boehringer; stock
solution IOmglml, stored at -20°C). All incubations were carried out for 30 minutes at
37°C. The reactions were terminated by the addition of 3,4-dichloroisocoumarin to a
final concentration of O.lmM (stock solution 4OmM, stored at -20°C; Boehringer) to
the chymotrypsin and V8 treated samples and 5mM EDTA (ethylenedinitrolo
tetraacetic acid, Merck) to the thermolysin sample. After digestion, the samples were
immediately frozen in liquid nitrogen and stored at -20°C to prevent further digestion.
All samples were heated for 3 minutes at 95°C in Laemmli sample buffer just prior to
electrophoresis.
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Detergent extraction and sodium carbonate treatment of IMV and PNS: Viral
membranes were separated from the cores as described by Oie (1981) with the
following modifications: virus was (i) disaggregated before treatment by a 30 sec
sonication in a water bath sonicator, (ii) incubated with 1% NP-40 ( Sigma) and
20mM OIT (Sigma) in 10mM Tris, pH9 rather than lOOmM Tris pH 7.5. The
incubation was carried out for 30 mins at 37°C with gentle shaking. The sample was
then loaded on top of a 36% sucrose cushion and spun in an airfuge at 26psi for 30
mins to separate the membranes, which remained on top of the sucrose cushion, from
the cores which pelleted. The cores were subsequently incubated with 0.5%
deoxycholate (DOC, Sigma) and 0.5% sodium dodecyl sulphate (SOS, Serva) at 56°C
for 10 min to ensure solubilization prior to adding Laemmli sample buffer.
For the TX-114 extraction (1), following a brief sonication, intact viros was
solubilized in an equal volume of 2% TX-114 in 300mM NaCI, ImM OIT and 10mM
Tris pH 10. An additional 400 rt of 1% TX-114 and lSOmM NaCI in 10mM Tris, pH
9was added and the mixture was incubated at 37°C for IS minutes followed by 20
minutes at 4°C and centrifuged for 2 minutes at 14,OOOrpm to separate the phases.
Both phases were subjected to a second round of TX-114 extraction. TX-114
extraction of radiolabelled post-nuclear supernatants from cells infected in the
presence of rifampicin (see above) was performed in the same way, with the exception
that the OIT was omitted. For the Na2C03 extraction of post-nuclear supernatants
from cells infected in the presence of rifampicin, the pH of the sample was adjusted to
pH II by the addition of an equal volume of 200mM Na2C03. The sample was
incubated for 30 minutes on ice and then spun at 150,OOOxg (Beckman TLAlOO
rotor) to pellet the membranes. All samples were concentrated by acetone
precipitation at -2()OC and the pellet dissolved in Laemmli sample buffer or fIrSt
dimension lysis buffer prior to electrophoresis.
Cloning, transfection and in vitro translation of A4L: Gene A4L from vaccinia
strain WR was PCR amplified using the following primers ;
TCGGMTICAATITfAAAGC (EcoRI site underlined) and
TITACfCGAAMGCITGAIT (HindllI site underlined). It was then digested with
EcoRI and HindllI and inserted into plasmid pOEM? P39 was transcribed and
translated in vitro using pOEMA4L and a coupled T7-driven transcription/translation
system (Promega) according to the instructions of the manufacturer. When dog
pancreas microsomes (a kind gift from K. Schroeder and B. Dobberstein) were used,
they were added at 100 00280 units per translation. To remove endogenous mRNAs,
the microsomes were treated with micrococcal nuclease (Sigma) before translation
(Krijnse Locker et al., submitted). Soluble p39 was separated from (putative)
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membrane bound protein by pelleting the membranes in a Beckman airfuge through a
cushion ofO.5M sucrose in RM-buffer (50mM Hepes-KOH, pH 7.5, 50mM KOAC,
2mM MgAc, IroM 017) for 10 minutes at 24 psi. All fractions were diluted in 500fJl
of detergent solution, and SOS was added to a final concentration of 0.2% along with
2J.1l of the anti-p39 antibody. The subsequent immunoprecipitation steps (as described
in (29) were followed by analysis on 15% SOS-PAGE.
For the transient expression in HeLa cells, A4L was cloned into the pCMUll plasmid
(a kind gift from Tommy Nilsson; (45) using Xbal and BAMBI. As the A4L
sequence contained both these restriction sites a two step cloning was performed.
First the 5' region of A4L was inserted into pCMUll using Xbal digested pGEMA4L.
Similarly the 3' end of A4L was digested from pGEMA4L and insertion of A4L into
pCMUll was completed to generate the vector pCMUllA4L. Transient transfection
was then performed according to Paabo et ale (1986) using pCMUllA4L and cells
were fixed at 48 hours POst-transfection and immunolabelled as described above.
Gel electrophoresis and westem blotting: Proteins were separated using standard
SOS-polyacrylamide gel electrophoresis (SOS PAGE) (32) with a 15% resolution gel
and a 4% stacking gel. Samples were incubated in Laemmli sample buffer containing
1% SOS and 0.5% 8-mercaptoethanol for 5 mins at 95°C. In some experiments,
samples dissolved in ftrSt dimension lysis buffer were subjected to 20 gel analysis
using a Biorad (Richmond, CAl mini 20 gel system. Samples were separated by
isoelectric focusing (IEF) from pH 4.0 to pH 7.0 in the first dimension and 15% SOS
PAGE in the second dimension. The gels were either fluorographed using Entensify
(Ou Pont de Nemours, Brussels, Belgium) or electrophoretically transferred to
nitrocellulose membranes for immuno-blotting, using the BioRad semi-dry transfer
system. The nitrocellulose was blocked in PBS with 0.2% Tween 20 and 5% non-fat
skim milk (PBS-T milk) overnight at 4°C prior to incubation with anti-p39 serum
diluted I: 10,000 in PBS-T milk. The nitrocellulose was then incubated with
horseradish peroxidase tagged goat anti-rabbit antibody (Biorad). Antibody was
detected by ECL (Amersham Life Sciences, England).
Gel filtration: In vitro translated p39 was resolved by high performance size-
exclusion chromatography (HPSEC, Gilson ,France). The 5 J.UIl TSKG2000 SWXL
column (Toyosoda Inc., Japan) was precalibrated with a mixture of gel filtration
molecular weight standards (ferritin, 44OkD; catalase, 232kD; bovine serum albumin,
66kD; carbonic anhydrase, 29kD and cytochrome c, 12.4kD). The column was then
pre-equilibrated with 50mM Na2P04 and lOOmMKCI, pH7.4, and IJ1l of sample was
injected into the column.
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RESULTS:
Identification of p39 (A4L) and synthesis of antibodies: As a fmt step towards the
characterization of p39, we decided to ensure its identity by peptide sequencing. A
43kD band, reactive by immunoblot with the antisenun raised against the complete
p39 (7), was excised from an SDS polyacrylamide gel and sequenced using Edman
degradation. Two peptides were found that showed a 100% homology to the gene
product of the vaccinia WR A4L open reading frame. This protein has a predicted
molecular weight of 30.9kD but, since it has been previously referred to as p39 due to
its mobility on gels (7,33), we adhere to this terminology throughout this paper. To
facilitate further characterization studies, we raised a COOH-terminal peptide
antibody against residues 267 to 281 of p39 which also recognised p39 on western
blots (data not shown).
p39 labels viral factories by immunofluorescence microscopy: We fmt
investigated the localization of p39 in infected cells at the light microscopy level.
Infected HeLa cells were fIXed at 8 hours post infection and labelled with the COOH-
terminal specific peptide antisenun. As can be seen from figure 1, clear labelling of
structures in the peri-nuclear region of the cell could be detected. This labelling co-
localized with the viral DNA factories which were identified by Hoechst-staining
(arrowheads in fig. Ib). In addition, p39 antisenun decorated punctate structures
throughout the cell, which probably represent individual virus particles (arrows in fig.
la).
Electron microscopy localisation of p39: A more precise localization of p39
throughout the different stages of viral assembly was subsequently carried out using
immunolabelling of thawed cryosections from aldehyde fIXed infected cells. The
earliest viral structures to appear in infected cells are termed viral factories (2, 20, 25)
(F in fig. 2a). These electron dense structures, which are predominantly found in the
peri-nuclear region, labelled strongly with antibodies against p39 in their central
region. From these viral factories crescent shaped membranes develop (fig. 2a). p39
was preferentially associated with the viroplasm underlying these membranes, with a
very low amount of label occasionally visible on the membranes themselves (arrows
in 2a). These "crescents" eventually form IVs (fig. 2b) which labelled throughout the
electron-dense viroplasm with anti-p39 antibodies. The labelling with anti-p39 at
these different early stages of assembly resembles the pattern that is seen with
antibodies against vaccinia-core proteins, such as p4a or p65 (11,54,58).
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As the virus particles mature to form IMV (IMV in figs. 2b and g), the p39 labelling
was found predominantly in the space between the newly developed core structure and
the outer IMV membranes, i.e. in the space between the two visible IMV membrane
proflles (see introduction). Panels c to h of figure 2 depict what we believe to be the
different stages of viral assembly with p39 labelling. Figures 2c and 2d show
developing IVs. The "viroplasm", which is being present in these structures, labels
strongly with anti-p39. These IVs have not yet packaged the DNA which is visible
above the virion in figure 2d and is clearly devoid of any labelling (arrowhead in 2d).
Figure 2e shows an IV which has packaged its DNA, which is visible to one side of
the particle (arrowhead). A transitional intermediate between the IV and the IMV is
shown in figure 2f, where the core structure is beginning to form. At this stage of
development, p39 appears to be excluded from the centre of the developing core and
is found in the space between this and the surrounding IMV membranes. The IMV
(fig. 2g) and lEV (fig. 2h) show a similar labelling pattern, with labelling of the space
between the core and the surrounding membranes.
We also investigated the localization of p39 in cells which were
infected in the presence of rifampicin, which blocks viral assembly prior to the IV-
stage (19, 38, 42),. When cells were infected in the presence of rifampicin, typical
electron dense structures called rifampicin bodies (RB in fig. 3a) were observed in the
cytoplasm close to the nucleus (N in 3a) (19,42,54). As for the viral factories, the
rifampicin bodies were strongly and uniformly labelled throughout by antibodies
against p39. These rifampicin bodies were surrounded by membrane structures
which, after release of the rifampicin block, formed the characteristic crescent shaped
membranes (stars in fig. 3b). There was only a very low amount of p39 labelling on
these membranes (within the .200m resolution of this labelling method, (18), whereas
the core material labelled very strongly. As maturation continued the IVs developed
(fig. 3b), the viroplasm of which labelled strongly with p39. In addition to the
rifampicin bodies, another especially distinct structure can be observed in cells
infected in the presence of rifampicin. These are crystalline-like arrangements of
DNA (D in figs. 3a and b), which are prevented from packaging into virions due to the
rifampicin block. Consequently they accumulate into crystalline arrays which are
much larger than those seen in normally infected cells. These rifampicin-induced
periodic DNA structures were also devoid of any p39labelling.
The localization of p39 in the IMVs was subjected to a closer
inspection by processing purified IMV for cryosectioning and subsequent
immunolabelling with anti-p39 (fig. 3c). In these sectioned particles, spike-like
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protrusions, which have been previously described (4, 9, 47) can be seen to extend
outwards from the internal core structure (arrowheads in 3c). The structure,
composition and function of these spikes is unknown. Recent evidence makes it
conceivable that the spikes may in part be composed ofp39 (47) and the co-
localization of the p39 labelling with the spikes in figure 3c further support this
possibility. In some views of the purified IMV particles, the whole virion labels with
p39, but this is probably due to the plane of the section through the virus particle, as
any particle which is sectioned between the core and the membranes may label all
over this accessible surface.
ImmunolabeUing of intact and treated IMV particles: In order to confmn the
localization of p39, electron microscopic experiments were performed, in which
purified IMV preparations were subjected to different treatments on the EM grids,
followed by immunolabelling and negative staining. Intact IMV particles did not
label significantly with antibodies against p39 (fig. 4a). This is in stark contrast to the
labelling obtained for another vaccinia protein, pl4 (A27L; fig. 4b), previously
described as being exposed on the outside of the virion (52). As can be seen from
table I, intact IMV labelled with anti-p39 only occasionally, with less than I gold
particle per virion. A small proportion of particles which were disrupted by the
preparation also labelled strongly (data not shown). On treatment of the particles with
NP-40 and orr, a classical method used to remove IMV membranes (10, 43), the
labelling with p39 increased dramatically (inset in fig. 4a), while pl41abelling was
lost (inset in fig. 4b).
The data in table I show the corresponding numerical values for the
p39 labelling. When viral particles were treated with NP 40 alone, there was very
little increase in labelling. However, treatment with O'IT alone caused a significant
increase in the number of gold particles per virion. This is in agreement with other
data using a novel cryo electron microscopy immunolabelling procedure which
showed that O'IT alone is sufficient to cause a dramatic loosening of the membranes
surrounding the IMV (47). In this process the core became exposed and labelled
strongly on its outside with antibodies to p39. In our experiments, a combination of
both NP 40 and orr caused an almost 500-fold increase in labelling relative to the
untreated control, indicating that p39 is associated with the external surface of the core
structure.
p39 is protected from protease digestion in intact IMV particles: We confmned
the intemallocation of p39 by carrying out experiments ill which intact purified IMV
were treated with different proteases. Virions were incubated with increasing
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concentrations of proteinase K from 5 to 300IJ,g/ml for 30 minutes on ice. Under these
conditions, even the highest concentrations of proteinase K did not cause any
digestion of p39, while two membrane proteins which are exposed on the outside of
the IMV, p32 (08L) and pl4 (A27L) (52), were completely digested (fig. 5a). Other
core proteins such as 4a14b (AIOL and A3L) and pll (FI8R) were also protected.
Additional proteases, chymotrypsin and thermolysin, failed to digest p39, while they
removed p32 and pl4 from the outside of the virion (fig. 5b). V8 had no effect, even
on these latter membrane proteins. When longer incubation times of 2 hours were
used, the core proteins were eventually digested (results not shown), in agreement
with our previous studies (47). When NP40 and 017 isolated cores were treated with
protease for 30 minutes, the particles were completely digested (ascertained by
electron microscopy), and there were no polypeptide bands, other than small digestion
products, remaining on the gel (data not shown).
p39 associates with viral membranes: Kyte and Doolittle hydrophobicity plots of
the p39 sequence show that it does not have any hydrophobic sequence typical of
membrane spanning proteins, i.e. a stretch of 17 to 22 hydrophobic amino acids that
may adopt an alpha helical structure .but, data in the literature showed that a small
amount of p39 was found in the membrane fraction after NP 40 and 017 treatment
(33). Therefore we decided to undertake a detailed biochemical characterization of
p39. We used a number of different criteria which are widely used to categorize the
physical properties of proteins. First, the membrane proteins of purified IMV were
extracted using a classical method for vaccinia virus which involves removal of the
viral membranes using a combination of 1% NP 40 and 20mM 017, along with some
modifications which improved the extraction of membrane proteins, such as p32 (see
Materials and Methods). Following this treatment, about 60% of p39 remained with
the core fraction while the remaining 40% was in the membrane fraction (fig. 6a). As
expected, the core proteins 4a, 4b, p25 and pII were present exclusively in the core
fraction. The extraction of p39 was highly variable and in some experiments the
majority of p39 was found in the membrane fraction. When separated on 20 gels (fig.
6b), the p39 pattern appeared complex as the protein was resolved into a number of
different spots, the identity of which were confumed by western blotting (data not
shown). This pattern is very similar to that seen in 20 gels by Oie and Ichihashi
(1981), where this protein is referred to as p37.
In another series of experiments, purified IMV were subjected to
treatment with TX-114. Following phase separation, TX-114 separates proteins
predominantly according to their hydro~bicity,with hydrophobic proteins tending to
partition into the detergent phase and hydrophilic proteins into the aqueous phase (1).
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Since membrane proteins contain hydrophobic sequences that anchor them in the
membrane, this phase separation can be operationally used to separate membrane
proteins from soluble proteins. Using this extraction technique, p39 was found
completely in the detergent phase indicating that it behaves more like a membrane
protein (fig. 6c, lane 7). In order to study its behaviour in the absence of IMV
formation, cells were infected in the presence of rifampicin to block virus assembly.
Post-nuclear supernatants from these cells were treated with TX-114. Again, p39 was
found exclusively in the detergent phase, as was p32 (D8L) which has been previously
described as a membrane protein (52) (fig. 6c lane 3). These results were unexpected
due to the predicted hydrophilic nature of p39 by the Kyte and Doolittle algorithm.
In order to further characterize the membrane association of p39, post-
nuclear supernatants from rifampicin-blocked, infected cells were treated with
Na2C03. This treatment is typically used to establish whether proteins are associated
with membranes in a peripheral or integral manner (15). The sample was adjusted to
pH II by adding an equal volume of 0.2M Na2C03, which removes the peripherally
associated and luminal proteins, after which the membranes, along with their integral
proteins, were separated from the soluble proteins by centrifugation. In such
experiments, approximately 60% of p39 was found associated with the pelleted
membrane fraction (fig. 6c lane 5), while the remainder was present in the supernatant
(fig. 6c lane 4).
When isolated IMV were subjected to a single round of solubilization
with 7M urea for 60 minutes at 37°C, approximately 30% of p39 was extracted,
despite the fact that most of the membrane proteins, with the exception of p14
(A27L), a soluble, peripheral membrane protein, and a protein with a molecular
weight of approximately 6OkD, remained in the virion (not shown).
I" vitro and ill vivo translation studies show that p39 is not an integral membrane
protein: The biochemical results encouraged us to further investigate the membrane
association of p39. In order to ascertain by an independent approach whether p39 is
an integral membrane protein or merely peripherally associated with membranes, for
instance via protein-protein interactions, the gene for p39, A4L, was cloned and
inserted into the pOEM vector under the control of the T7 promoter in order to carry
out in vitro translation and membrane translocation experiments. Upon in vitro
translation and immunoprecipitation with antibodies to p39, three bands could be
detected, the most prominent of which (upper bands in fig. 7) co-migrated with p39
immunoprecipitated from IMV (fig. 7 lane 7). The faster migrating species are
possibly due to incomplete translation products. When in vitro translated p39 was
treated with TX-114, most of the protein was found in the detergent phase (fig. 7, lane
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2) showing, again, that p39 behaves as a "hydrophobic" protein, even in the absence
of other viral proteins. When microsomes were added to the translation system at the
beginning of the reaction, p39 failed to insert into these membranes suggesting that it
is not a typical endoplasmic reticulum-SYnthesised integral membrane protein (fig.
7,lane 5).
, p39 was also expressed transiently in HeLa cells using pCMUll to transfect
the A4L gene. In transfected cells, p39 gave a predominantly cytosolic staining
pattern. However, as this labelling was very strong, it could not be ruled out that
some underlying membrane-like labelling was also present (fig. 8a). Further studies
at the ultrastructural level will be needed to establish this point.
We also investigated whether the membrane association of p39 could be
accounted for by fatty acid acylation. However, metabolic labelling with 3H-
palmitate or 3H-myristate, followed by immunoprecipitation with anti-p39, indicated
that p39 was not modified by the addition of fatty acids (results not shown).
However, immunoprecipitation experiments with p39 showed that a number of other
proteins were co-immunoprecipitated, with three of these especially abundant (fig 9a,
lane 6). One of these proteins was identified as p21 (gene AI7L) by
immunoprecipitation with antibodies against the C-terminal region of this protein (fig
9a, lane 7) (28). This is an integral membrane protein which is present in the inner
membrane surrounding the IMV (28). The identity of the other bands remains to be
established.
Is p39 glycosylated? As early as 1940 it was suggested by Smadel et ale (1940) that
a vaccinia virus, heat stable, basic protein contained small amounts of glucosamine
(SO). Moreover, a number of different groups have reported the presence of a
glycoprotein with an electrophoretic mobility of 37-40kD (16, 22, 23, 40, 44). This
protein, which can be completely extracted from virions by two rounds of urea
extraction (23,43), has not yet been identified and therefore we investigated whether
p39, which has a similar mobility, could be this glycoprotein. When infected cells
were labelled with 3H-glucosamine, the radiolabelled sugar which was reported in the
previous studies, a faint band of very similar molecular weight was found (fig 9a, lane
1), but unfortunately was no longer detectable when combined with
immunoprecipitation with anti-p39 antibodies (fig 9a, lane 3). Also when IMV was
subjected to blotting with a monoclonal antibody specific for the O-linked N-acetyl
glucosamine modification (51), a modification that is commonly seen in an ever
increasing list of cytoplasmic proteins (21), a protein which corresponded in
molecular weight to p39 was detected (data not shown). However, these results were
not reproducible and so we cannot unequivocally conclude whether or not p39 is
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modified by the addition of O-linked N-acetyl glucosamine residues. Thus our results
still leave open the possibility that p39 represents the glycoprotein first described by
Smadel et al (1940) and further characterized by Holowczak (1970), Garon and Moss
(1971) ,Moss et ale (1973), Ichihashi and Oie (1980) and Die and Ichihashi (1987).
As most of the proteins which posess this cytoplasmic Q-linked sugar are also
phosphorylated (21), we also investigated whether p39 was phosphorylated. While a
number of viral proteins were labelled by 32Phosphate, immunoprecipitation of p39
from the 32p labelled virus preparation failed to yield any band suggesting that p39 is
not phosphorylated (results not shown). We also tested for N-linked glycosylation by
infecting the cells in the presence of tunicamycin, a N-glycosylation inhibitor,
followed by immunoprecipitation with anti-p39. There was no apparent shift in
molecular weight of p39 synthesised in the presence of the drug (fig 9a, lane 5)
suggesting that it is not post-translationally modified by N-glycosylation.
Pulse chase experiments: p39 showed a pattern of multiple polyPeptides on a 2D
gel, similar to the pattern observed by Oie and Ichihashi (1981, referred to as p37).
We next investigated if these different forms were synthesized in a temporal fashion
during viral infection by performing pulse-chase labelling experiments followed by
separation on 2D gels. In these experiments the different forms of p39 indeed
appeared at different stages during the viral maturation. These different migrating
forms have been numbered 1 to 6 in fig 9d. The larger central form (no. 1) appeared
first and was seen after a 5 minute pulse with a very faint trace of 5 and 6 (fig. lOa).
After a 30 minute chase a fourth form (no. 2) appeared (fig. lOb). Two further species
(nos. 3 and 4) were apparent after 60 minute chase (fig. lOe) with little change in the
pattern after 120 minutes chase (fig. IOd).
p39 does not form oUgomers in vitro: The spike-like structure, observed between
the membranes and the core in the IMV by all electron microscopic techniques, is
approximately 20nm in length. Therefore, if p39, does form part of this spike, it
would most likely need to oligomerize, either forming homo-oligomers or hetero-
oligomers with other core proteins. In order to find out if p39 forms homo-oligomers
and to obtain a more accurate measure of the apparent molecular weight, in vitro
translated p39 was subjected to high performance size-exclusion chromatography. As
can be seen in figure 11, p39 behaved as a monomer, eluting from the column with a
molecular weight corresponding to 41.5 (+/- 5%). The peak at 16.3 minutes, which is
less than 1% of the total protein, corresponds to a molecular weight of 122kD (+/-
5%). However, it was confirmed that this peak did not correspond to p39, as the
38
Chapter 2
A280nmlA220nm ratio was different. Two other smaller peaks of less than 10kD were
also eluted. This data indicates that p39 does not form homo-oligomers in vitro.
These eXPeriments were very difficult to Perform on in vivo synthesised protein as p39
cannot be isolated from virions or infected cells without the use of detergent and a
reducing agent, both of which could disrupt any potential oligomerization. Therefore
it remains possible that p39 may form homo-oligomers, or even hetero-oligomers, in
the virus.
DISCUSSION:
The gene product of A4L, a late vaccinia gene, has been previously described as a
core protein (33). The amino acid sequence of this protein indicates a predicted
molecular weight of 30.9kD, but it migrates anomalously on SDS gels at a position of
39kD and was therefore referred to as p39 in previous studies (7, 33, 46). It has an
unusually high proline content of 30 residues, concentrated mainly in the central
region of the protein, which account for 10.6% of the entire protein. From sequence
analysis there are also a number of internal rePeats in p39 which could indicate gene
duplication. It has a predominantly hydrophilic nature as determined by the Kyte and
Doolittle algorithm (31) and does not posses a long stretch of hydrophobic amino
acids, which protein prediction (PhD prediction of secondary stnlcture, EMBL)
indicates could form a putative membrane-spanning alpha helix. Sequence
comparison (Blast programme, NIH) suggests that p39 has some homology with
proteins which have a coiled-coil stnlcture, such as eutrophin and myosins.
We investigated the localization of p39 throughout the early assembly stages of
vaccinia using immunogold labelling of cryosections. p39 labels the viral factories
very strongly and also the central region of the IVs, in a manner which resembles the
more typical core proteins, such as p4a (11, 58), with only a very low amount of
membrane association apparent. However, the Na2C03 eXPeriments indicate that a
significant amount of p39 is associated with membranes in cells which were infected
in the presence of rifampicin, showing that even before virion assembly has
commenced p39 attains a certain degree of membrane association. Upon transition of
the IV to the IMV, the pattern of p39 labelling changes dramatically. In the IMV, p39
is located between the two membrane profiles, which are apparent in electron
micrographs (fig 2b,g and 3c). According to our current interpretation of the IMV
structure (see introduction), this would mean that p39 is present in the space between
the core and the inner of the two tightly apposed membranes. In this model p32
(D8L) is located in the outer of the two membranes (52) while p21 (A17L) is an
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integral protein of the inner membrane (28). This interpretation of the IMV structure
is supported by the fact that when isolated IMV are treated with DIT alone, the
cisternal membranes surrounding the IMV are loosened and begin to come off the
vims as one continuous membrane sheath, thereby exposing the underlying core (47) .
This fact could also explain why p39, a core-associated protein, produces a strong
humoral immune response in humans (7, 34), as when the virus particles are disrupted
in any way, the highly abundant p39 is readily exposed on the outside of the cores.
Upon DIT treatment of the IMV, spike-like structures which are present between the
outer surface of the core and the surrounding membranes of the IMV (4, 9) become
exposed and recent work suggested that p39 might be a component of these spikes
(47). All our electron microscopy results further support this possibility as both
chemically prepared cores, as well as "natural" cores which arise during vaccinia entry
into cells (Snijder et al, manuscript in preparation), are labelled by anti-p39 on their
external surface where the spikes are exposed.
On our gels, p39 had a molecular weight of 43k which is even higher than the 39kD
previously reported (7, 33, 46), and when ascertained by gel filtration, the molecular
weight of the native protein was 41kD. It is difficult to reconcile such a large
discrepancy between the predicted molecular weight of 30.9kD and the apparent
molecular weight, even by co- or post-translational modifications. Radiolabelling
eXPeriments with 32p, 3H-myristate and 3H-palmitate indicated that p39 is neither
modified by fatty acid acylation nor by phosphorylation. We also showed that this
protein is not modified by the addition ofN-linked oligosaccharides. However, there
was an indication that p39 may be glycosylated by the addition of N-acetyl
glucosamine, suggesting that it may be the glycoprotein reported by (16, 22, 23,40,
43), but due to the very low levels of 3H-glucosamine which were incorporated, this
point will need further investigation. Therefore, the aberrant migration of p39 on
denaturing gels cannot be reconciled by co- or post-translational modifications, but
may in part be due to the high number of proline residues.
Although our detailed sequence analysis failed to reveal a typical membrane spanning
region, our biochemical data show that p39 has many physical characteristics typical
of a membrane protein. Therefore, we investigated the possibility that p39 may be
membrane-associated through the addition of a lipid moiety. It has indeed been
shown that a number of vaccinia proteins can be acylated by the addition of palmitate
or myristate (3, 13, 14). Albeit, the membrane association ofp39 cannot be accounted
for by a myristate of palmitate anchor, as the protein does not label with either 3H-
myristate or 3H-palmitate. Moreover, in vitro translation and translocation
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experiments indicate the protein does not associate with rough endoplasmic reticulum
membranes. Therefore, we postulate that p39 attains its membrane association
through interaction with other viral membrane protein(s) in the inner of the two
membranes surrounding the IMV. Co-immunoprecipitation experiments suggest that
p21 (AI7L) could possibly interact with p39. We have recently identified p21 as an
integral protein in the inner membrane of the IMV which spans this membrane four
times, with both the N- and C-termini exposed on membrane surface which faces the
core (28). Thus, the N- or C-terminal regions of p21, as well as the loop region
between residues 98 and118, are ideally located to interact with p39.
Collectively, our data suggest the following model for p39 in the context of vaccinia
assembly. We propose that p39 is synthesised on free ribosomes in the cytosol and is
then transported to the viral factories, as it labels the "viroplasm" of these factories. It
is packaged into the IV, apparently as part of this material, possibly facilitated by its
association with viral membranes even at this early stage (as suggested by the
Na2C03 extraction of membranes from cells infected in the presence of rifampicin)
and, subsequently, is predominantly located in their central region. However during
transition to the IMV, a new internal core structure develops and p39 is now located in
the space between this newly formed core and the surrounding cisternal envelope, an
ideal position to act as a matrix protein and to make the link between the core
structure and the surrounding membranes. The identity of the spike-like structures,
long seen on the surface of the core, must be further investigated in order to establish
if p39, possibly along with other proteins, is a structural component of this spike.
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Table 1. Labeling of intact IMV with a p39 on EM grids
Treatment G>ld partLcles! firion ratio' b
(mean +/- S::M) a
Control 0.1 +/- 0.01 1.0
NP-40 2.5 +/- 0.45 25
OTT 7.5 +/- 1.45 75
NP-40/0TT 47.4 +/- 2.08 474
Trypsin 3.1 +/- 0.47 31
Proteinase K 0.6 +/- 0.02 6
Table 1 : Purified IMV were adsorbed to formvar- and carbon-coated 100 mesh
electron microscopy grids and treated as described in Materials and Methods.
The grids were subsequently blocked and labelled with anti-p39 antibodies
followed by IOnm protein A-gold.
a Mean values +/- standard error of the mean (SEM) (n=20).
b For the ratios, the data from the treated samples were compared to the
untreated control sample which was normalised to 1.
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FIGURE LEGENDS:
Figure 1: Immunofluorescence localization of p39 in vaccinia infected HeLa cells
8h after infection. Panel a) shows an infected cell labelled with antibodies against
p39. There is strong labelling of the Peri-nuclear region of the cell most likely
corresponding to the viral factories, which can also be seen by Hoechst staining of
DNA (arrowheads in panel b). The punctate structures seen throughout the cell
(arrows in a) probably represents individual virions. Scale bar 20fJJD.
Figure 2: Immunolabelling of thawed cryosections of fixed HeLa cells, infected with
vaccinia for 8h, with antibodies against p39. Panel a) shows a viral factory (F) which
labels strongly with anti-p39. Crescent shaPed membranes (star) are visible
protruding from the factories, which display a very low amount of p39 labelling
(arrows). In panel b) immature virions (IV) clearly label in their central region with
antibodies against p39. In the intracellular mature virus (IMV) p39 labelling is
observed in the space between the core and the enveloPe. The IMVs always apPear to
label less than the IVs, most likely due to a problem of access of the antibody to p39
in the IMV. Panels c) through to h) show virus particles at various stages during
maturation labelled with anti-p39. In c) a developing IV is packaging "viroplasm"
while in d) the IV has not yet packaged DNA, which is visible above the particle in a
crystalline-like array (arrowhead). In panel e) the DNA (arrowhead), which does not
label with p39, has been packaged and is seen as an electron dense structure on the left
side of the virion. An intermediate stage between the IV and IMV is seen in f) where
the label starts to associate with what is interpreted as the surface of the developing
core. The IMV in (g) and EEV in (h) label between the core and the IMV membranes.
Scale bar 200nm.
Figure 3 : Cryosections of cells infected for 16h in the presence of rifampicin and
immunolabelled with anti-p39. In panel a) rifampicin bodies (RB) are clearly visible
which label strongly with antibodies against p39. Also visible are crystalline arrays of
DNA (0) which are devoid of labelling. Panel b) shows viral crescents (stars)
protruding from the rifampicin bodies, as well as immature virions (IV), seen here 15
minutes after rifampicin release. In panel c) purified IMV were used to make Pellets
which were cryosectioned and labelled with anti-p39. The label is most frequently
found in the region between the core and surrounding IMV membranes. This
labelling appears to colocalise with the spikes which extend between the core and
IMV membranes (arrowheads). Scale bar in (a) 4OOnm, in (b) 250nm and in (c)
5Onm.
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Figure 4 : Immunolabelled and negatively stained IMV viewed by electron
microscopy. Purified IMV were adsorbed to an EM grid and labelled with antibodies
against a) p39 and b) p14, followed by protein A gold. The inserts show IMV
particles which were treated with 1% NP 40 and 20mM O'IT to remove the viral
membranes prior to labelling. In contrast to anti-p14, antiserum against p39 does not
significantly label intact IMV. However, after NP 40 and O'IT treatment, the cores
are devoid of p14 labelling, while the p39 labelling has dramatically increased. In
panel A, virus particles are visible which are open to the negative stain (arrowheads)
but do not label with anti-p39, suggesting that the epitope is still masked by the
surrounding envelope. Scale bars in (a) 200nm, in the inset l00nm; in (b) 200nm.
Figure 5 : p39 is not digested during protease treatment of IMV. a) 3SS labelled and
purified IMV was treated with proteinase K for 30 mins on ice. Lane 1; mock treated
control; lanes 2-9; samples treated with 5, 10, 20, 30, 50, 100, 200 and 300 Jlglml
proteinase K respectively; lane 10, untreated IMV sample. The positions of 4a, 4b,
P11 and p39 which are not digested, as well as the position of p32 which is sensitive
to proteinase K, are indicated on the left. b) IMV was also subjected to treatment with
50Jlglml a-chymotrypsin (lane 1), l00Jlglml thermolysin (lane 2), 250Jlglml V8 (lane
3) at 37°C for 30 minutes. In lane 4 samples were treated with 50Jlglml proteinase K
for 30 minutes on ice. Lane 5, untreated control IMV. The positions of the major
core proteins, 4a, 4b and p11, as well the membrane protein p14 are indicated on the
left, with the positions of three molecular weight markers (45kD, 30kD and 14kD)
indicated on the right. p39 is not digested by any of the proteases assayed, even at
concentrations of 300Jlglml of proteinase K indicating it is protected from protease
treatment due to its intemallocation.
Figure 6 : Membrane association of p39. a) 3SS-labelled purified IMV was incubated
with 1% NP 40 and 20mM O'IT for 30 minutes after which the sample was
centrifuged through a 36% (w/v) sucrose cushion to pellet the cores. Lane 1 shows
the membrane proteins, while lane 2 comprises the core proteins. Lane 3, untreated
control IMV. Approximately 40% of p39 is found in the membrane fraction along
with other membrane proteins like p32 (indicated on the left). The core proteins 4a
and 4b (indicated on the left) are found exclusively in the pelleted core fraction. b)
20 gel electrophoresis of NP 40 and O'IT treated samples. Isoelectric focusing was
used in the fll'St dimension and SOS polyacrylamide gel electrophoresis in the second
dimension. The top panel shows the pelleted core proteins while the bottom panel
shows the membrane protein fraction. When separated in this fashion, it is clear that
p39 separates into both the membrane and core fractions and that it is composed of a
48
Chapter 2
complex pattern of polypeptides. The protein pattern on the right side of the
autoradiogram represents the same samples which are only subjected to SDS-PAGE.
The position of p39 is indicated on the right. The pH range of the IEF is shown at the
bottom of the gels. c) Post nuclear supernatants from infected cells were subjected to
treatment with 1% TX-114 or Na2C03. Lane 1 untreated control PNS. Lane 2 shows
the aqueous phase and lane 3 the detergent phase of TX-114 treated PNS samples.
Lane 6 shows the aqueous phase of TX-114 treated purified IMV and lane 7 the
detergent phase. p39, as well as p32 (indicated), are found exclusively in the
detergent fraction under both conditions, indicating their hydrophobic nature. Lane 4
comprises the supernatant and lane 5 the pellet fraction from Na2C03 treated PNS.
Approximately 60% of p39 is found associated with the pelleted membranes from
infected cells, while p32 quantitatively pellets, indicating that p39 associates strongly
with membranes. Numbers on the right of a) and c) indicate the positions of
molecular weight marker proteins in kD.
Figure 7 : In vitro translation and translocation of p39. p39 was translated in vitro
using a rabbit reticulocyte lysate system. The samples were then immunoprecipitated
with antibodies against p39, which yielded three different bands (lane 8), the
uppermost of which co-migrates with p39 immunoprecipitated from IMV (lane 7).
The faster migrating bands are most likely due to premature termination or internal
initiation of the translation. Upon extraction of the in vitro translation reaction with
1% TX-114,. p39 is found almost exclusively in the detergent phase (lane 2) with only
a small amount of p39 apparent in the aqueous phase (lane I). In lanes 3 through to 6,
p39 was translated in vitro in the absence (lanes 3 and 4) or presence (lanes 5 and 6)
of dog microsomes, after which the soluble protein (lanes 3 and 5) was seperated from
the putative membrane-associated protein (lanes 4 and 6) by centrifugation. p39 does
not associate with rough microsome membranes when they are added co-
translationally, as indicated by the absence of p39 in the pelleted membrane fraction
(lane6). The number on the right indicates the 45kD molecular weight standard.
Figure 8: HeLa cells transiently transfected with p39. Panel a) shows transfected
cells labelled with antiserum against p39 that indicate a predominantly cytosolic
labelling, suggesting that p39 behaves as a soluble protein in the absence of other late
viral proteins. Panel b) shows a phase contrast image of the same field showing that
the morphology of the transfected cells, in comparison with the untransfected cells,
remained normal. Scale bar represents 5OJ.Lm.
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Figure 9: Immunoprecipitation of p39 from cells infected in the presence of 3H-
glucosamine, 35S or 32p. Panel (a): Lane 1, 3H-glucosamine labelled PNS and lane 2,
35S-labelled PNS without immunoprecipitation. A faint band apparently co-migrating
with p39 is labelled with 3H-glucosamine(lane 1). When this sample is
immunoprecipitated with antibodies against p39, the labelled protein is no longer
IU\(. ~
detectableA The major glycosylated band, running at approximately 90kD, most likely
represents the EEV HA protein. Lane 4 shows a control p39 immunoprecipitation
from 35S-labelled PNS, while lane 5 indicates that the molecular weight of p39 is not
affected by the addition of tunicamycin which prevents N-glycosylation. The co-
immunoprecipitation of p39 in lane 6 shows that p39 may interact with a number of
other proteins. One of these was identified as p21 (gene A17L) by
immunoprecipitation with antibodies against the C-terminus of this protein (lane7).
Io.nl. ~: I~MuW\Ofrecipi~ .. ; 0. IN" Ju~~i"e. IGbtJleJ PAJ$ wiHl .,.-p3,.
Figure 10 : Pulse-chase analysis ofp39. infected HeLa cells pulse-labelled for 5
minutes at 7 hours p.i. (a), and chased for (b) 30 minutes, (c) 60 minutes and (d) 120
minutes. The different forms of p39, that occured during the various chase times,
have been numbered 1 to 6 in (d). Initially the p39 pattern is quite simple with a
central major spot (no. 1) with some minor species visible (nos. 5 and 6). By 60 mins
chase and even more noticeably by 120 mins chase, the p39 pattern is more complex
with the central, most abundant form of p39 now surrounded by 6 other species of
varying intensity.
Figure 11 : A graph showing the elution profile of in vitro translated p39 after high
performance size-exclusion chromatography. The Y-axis represents the optical
density at 280nm while the elution time, in minutes, is shown on the X-axis. p39
eluted at 19.42 minutes, which corresponds to 41.5 +/- 5% when compared to the
calibration standards. Two smaller peaks of 8.9 and 7kD are also visible. The peak at
12.5 minutes is the void volume while the peak at 16.3 minutes corresponds to 122kD
but analysis of the A2S()nm!A220nm ratio indicated that it is not a trimer of p39.
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FIG. 2 lEV Induces actin tall forma Ion. a. Hela cells
mfected Ith a mutan vaCCInia stram, RS 12. b. Cells
Infected with wild-type WR I the presence of IMCSH. The
VIrUS IS concentrated In the pennuclear area of both cells
and there are no ac In tails. c. Viral particles are seen on
actin tails 1 h after IMCSH remo al. Scale bar. 50 11m.
ETHODS. Cells ere Infected Ith R or RS12 as
described above. IMCSH was added to a final concentration
of 10 Ilg mill h pos -infection. At 8 h post-infection cells
ere ashed Simes Ith PSS and fl ed h a er ashout.
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LEnERS TO NATURE
The intimate relationship between the lEV and the actin cyto-
skeleton suggests that the virus contains protein(s) that can asso-
ciate directly or indirectly with actin. In Listeria species and
Shigella. the proteins ActA. lactA and IcsA are critical for the
nucleation of actin filaments at the bacterium surface,s.24 26.
Sequence comparisons of the vaccinia virus genome with ActA.
lactA or IcsA failed to identify any OR F that contains signifi-
cant homologous sequences. One possible candidate for viral
interactions with actin is the A42R ORF. which is 32.1%
identical to human profilin27• However. deletion of A42R has
previously shown that it is not required for infectivity or release
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of mature virions27• Moreover. we found that vaccinia virus lack-
ing A42R is still able to form actin tails and projections (data
not shown). which is consistent with the recent observation that
profilin is not required for actin-based motility of Listeria in
the cell-free Xenopus system28 • Whether profilin is involved in
vaccinia motility will require further characterization. as the
virus may be able to utilize cellular profilin isoforms. Given
the similarities between the motility of bacterial pathogens and
vaccinia virus. we suggest that intracellular pathogens have
developed a common mechanism to exploit the actin
cytoskeleton for their own purposes. 0
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ABSTRACT
Our understanding of the interactions between the actin cytoskeleton and cellular membranes at
the molecular level is mdimentary. One system that offers an opportunity to examine these
interactions in greater detail is provided by vaccinia vims, which induces the nucleation of actin
tails from the membrane surrounding the virion. To further understand the mechanism of their
formation and how they generate motility, we have examined the structure of the actin tails in
detail. Actin filaments in vaccinia tails are organized so they splay out at up to 450 from the
centre of the tail and are up to O.75fJJll in length, which is considerably longer than those
reported in the listeria system. Actin ftlaments show unidirectional polarity with their barbed
filament ends associated with the surface of the virus particle. The overalorganization of actin
filaments in the vaccinia tail is very reminiscent of actin at the leading edge of motile cells.
Rhodamine-actin incorporation eXPeriments show that the first stage of tail assembly involves a
polarized recruitment of G-actin, and not pre-formed actin filaments, to the membrane
surrounding the virion. Incorporation of actin into the tail occurs by nucleation only from the
viral surface at a rate consistent with the in vivo speed of virus particles. As vims particles fuse
with the plasma membrane during extention of projections, actin nucleation sites previously in
the viral membrane become localized to the plasma membrane, where they continue to nucleate
actin polymerization in a manner analogous to the leading edge of motile cells.
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INTRODUCTION
A key mechanism in the virulence of any cellular pathogen is its ability to move from cell to cell
to facilitate spread of the infection. A group of unrelated bacterial pathogens Shigella, Listeria
and Rickensia, that are the causative agents of an number of important diseases including
meningitis, septicaemia, dysentery and shigellosis have indePendently developed a similar actin
based mechanism that is essential for their intercellular spread (Cossart, 1995, Cossart and
Kocks, 1994, Tilney and Tilney, 1993). Initially, the bacterium enters the host cell by
phagocytosis but rapidly escaPes into the cytoplasm where it grows and divides by lysis of the
phagosome. In the cytoplasm, the bacterium recruits a cloud of host actin which becomes
arranged into an actin comet at one pole of the bacterium. The bacteriwtis then able to move
around the cell by continued nucleation and unidirectional elongation of the actin filaments at the
bacterial surface while the tail remains stationary in the cytoplasm (Theriot and Mitchison,
1992). Ultimately, interactions with the plasma membrane and continued motility result in the
formation of long bacterial-tipped extentions that project from the cell surface. These Projections
are phagocytosed by neighbouring cells and a new infection cycle begins without the bacterium
being exposed outside the cell, hence escaping the humoral immune response of the host. The
ability to nucleate the formation of an actin tail is essential for the intercellular spread of these
bacteria, as mutants which are unable to recruit actin are non-virulent.
Bacterial pathogens are not the only infectious agents that have profound effects on the actin
cytoskeleton of their host cells. Many different viruses have been shown to disrupt or stabilize
the actin cytoskeleton (Bohn, et al., 1986, Giuffre, et al., 1982, Murti, et al., 1985, Tyrell and
Norrby, 1978). The best studied example is that of vaccinia virus, the prototype member of the
orthopox genus and a close relative of \IGr;ola vi,. Vaccinia, one of the largest and most complex
viruses known, has a programmed series of interactions with the host cell that involve wrapping
by two membrane cisternae of different subcellular origin during its assembly and maturation.
An intriguing characteristic of this assembly process of vaccinia virus is that it results in two
different infectious forms. The first infectious form, the intracellular mature virus (IMV), is
surrounded by a membrane cisterna derived from the intermediate compartment (Sodeik, et al.,
1993). Infectious IMV are released when the cell lyses due to the cytotoxic effects of infection.
Alternatively, a small proportion of IMV, .' - -- -,. - ~
can undergo a second wrapping step by a cisternal domain derived from the trans Golgi network
(payne, 1980, Payne and Krlstensson, 1985, Schmelz, et al., 1994). This form is called the
intracellular enveloped virus (lEV) and escapes from the cell by fusion of its outer membrane
with the plasma membrane of the host, thereby releasing the second infectious form call S'
€. ''''~''.extracellular enveloped virus (EEV) (Blasco and Moss, 1991, Dales, 1971, Morgan, ~. ';...." ~
" " .'~
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Payne, 1980). During the fusion of lEV with the plasma membrane, a small proportion of EEV
particles are not released into the media but remain associated with the outside of the cell. These
particles are refered to as cell-associated enveloPed virus (CEV) (Blasco and Moss, 1992).
The fIrSt indication that vaccinia virus was able to interact with the cytoskeleton during its
complex assembly process came from high voltage electron microscopy studies which showed
virus particles at the tips of large microvilli projections in infected cells (Stokes, 1976). These
projections were larger than the normal cellular microvilli which lacked virus particles.
Subsequent studies confmned that these vaccinia-tipPed projections contained actin, as well as
the actin cross-linking proteins alpha actinin, fI1amin and fImbrin but not tropomyosin or myosin
(Hiller, et al., 1981, Hiller, et al., 1979). Furthermore, inhibition of virus assembly prevented the
fonnation of the large microvilli suggesting that these structures were virally induced (Krempien,
et al., 1981).
In light of the effects of bacterial pathogens on the actin cytoskeleton we have recently re-
examined the effects of vaccinia virus on the actin cytoskeleton (Cudmore, et al., 1995).
Infection by vaccinia virus not only results in the formation of virally-induced microvilli on the
cell surface but also in the disruption of actin stress fibres and the formation of actin tails in the
cytoplasm of the host cell that are very reminiscent of those seen in bacterial systems. Studies
using a mutant virus which cannot form lEV, as well as infection with wild type virus in the
prescence of a drug which prevents lEV formation, demonstrated that it is the lEV that is able to
recruit actin to form tails. Vaccinia virus uses these actin tails to move around in the cytoplasm
of the host cell at a speed of 2.8 J1IIlImin and to project into and infect neighbouring cells
(Cudmore, et al., 1995). The existence of actin-based motility in vaccinia virus suggests that
diverse cellular pathogens have develoPed a common mechanism to exploit the host actin
cytoskeleton as a means to facilitate their spread between cells.
In order to learn more about the process of actin tail mediated motility, we have analyzed the
structure and dynamics of actin fI1aments in tails induced by vaccinia virus. Using rhodamine
actin incorporation into Penneabilized cells, we have shown that nucleation and growth of actin
filaments occurs in a polarized fashion from the viral surface. Furthermore, the appearance of
the actin filaments in the tails nucleated by the viral membrane is strikingly similar to the
organization and polarity of actin filaments at leading edge of motile cells.
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MATERIALS AND METHODS
Immunotluorescence microscopy: HeLa cells were grown, infected and fIXed at 8h post
infection (p.i.) as previously described (Cudmore, et al., 1995). Infected cells were labelled with
anti-14kD viral antibodies (Rodriguez, et al., 1985) and either rhodamine or bodipy phalloidin
(Molecular Probes). For maximium resolution, all immunofluoresence experiments were
examined and recorded with 63X or lOOX lenses in a Zeiss Axiophot microscope. Negatives
were printed and scanned on a flat bedscanner to convert prints to digital images that were
enlarged and annotated using the Adobe 3.0 software package.
Electron microscopy: HeLa cells were grown and infected with vaccinia virus strain WR at a
multiplicity of infection of 1 PFU/cell as described (Ooms, et al., 1990). For S1 myosin
labelling, infected cells were washed at 16 hours p.i. with ice cold PBS and incubated with
5mg/ml SI myosin in O.IM phosphate buffer pH 6.8 (PB) and 0.2 mg/ml saponin for 30 mins
on ice. The cells were washed twice with PB and subsequently fIXed in 1% gluteraldehyde, 2%
tannic acid and 50mM phosphate buffer pH 6.8 for 30 mins at room temperature. After another
wash in PB, the cells were post fIXed in 1% OS04 and 1.5% KFe(Cn)6 for 30 mins on ice in the
dark. Following three rinses in distilled water, the samples were dehydrated in 50% ethanol and
stained overnight in 70% ethanol saturated with uranyl acetate. The following day the
dehydration was continued and the cell monolayers were embedded in EPON. Parallel sections
of the embedded cell monolayers were cut using a Reichert microtome. Sections were post-
stained with 4% uranyl acetate for 5 mins followed by 1% lead citrate for 3 mins, and observed
in a Philips 400 electron microscope.
Cell permeabilisation experiments: For these eXPeriments the method of Symons and
Mitehison (1991) was used with some minor modifications. Briefly, HeLa cells were grown on
uncoated 11mm glass coverslips for 24 hours before infection with virus. At 8h p.i. the cells
were transferred to observation medium (OM; Bicarbonate free MEM buffered with 20mM
Hepes, pH 7.4, 10% FCS, penicillin and streptomycin) at 37°C. Before the experiment the cells
were cooled to room temperature and the subsequent experiments carried out at this temperature.
The coverslip was incubated cell side down on two drops of rinsing buffer (RB ; 20mM Hepes
pH 7.5, 138mM KCl, 4mM MgCh and 3mM EGTA) and and then permeabilised for 30
seconds on a drop of incubation buffer (IB ; RB plus 0.2mg/ml saponin). A 10 mg/ml stock
solution of rhodamine G-actin (Cytoskeleton, USA) stored at -80°C was pre-thawed, diluted
1:10 with G-actin buffer (2mM Tris pH8.0, O.lmM ATP, O.lmM DTT and O.lmM CaCh) and
clarified for 20 mins at 26psi in an airfuge at 4°C. It was then diluted to a fmal concentration of
1.0 or 0.3 J1M in mplus 1 mM ATP. The coverslips were incubated on 20 J1l drops of
rhodamine actin for various times from 5 secs to 10 mins. After incubation in rhodamine actin
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the cells were fixed in 3% PFA in CB for 10 mins. The coverslips were then penneablized in
0.1% TX-l00 for 1 min and further fluorescence labelling carried out as described above.
For myosin inhibition experiments 3,4-butanedione monoximide (BOM) was added to
rhodamine actin to a fmal concentration of 10 mM from a freshly made 1 M stock in water prior
to incubation with penneablized cells as described above.
All penneabilzation incubation experiments were examined and recorded using the EMBL
confocal microscope facility. The resulting aligned digital images were merged and false colour
added using the Adobe 3.0 software package.
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RESULTS
The structure of vaccinia actin tails: Cells stained with bodipy phalloidin 6 hours or later after
infection with vaccinia virus show numerous actin tails and projections that are not seen in
uninfected cells (Fig. 1). The number of actin tails and projections in each cell is variable,
between 1-2QO in the same infection eXPeriment but their number increases with longer infection
times. When virus particles extend from the plasma membrane the projections initially have a
broad and constant diameter along their their length (Fig. 1). However, as the projections
continue to extend, the region closer to the cell apPears withered and thin (Fig. 1).
Closer inspection of the apPearance of vaccinia-induced actin tails shows that although similar to
those of bacterial pathogens, there are a number of differences in their organization. Rather than
being smooth like those in the published images of bacterial comets, the vaccinia actin tails have
a somewhat splayed apPearance with branch like apPendages extending outward randomly along
their length (Fig. 2). These branches project out at an angle of about 45° with respect to the
central axis of the tail , towards the virus particle end. This splayed apPearance along the
complete length is seen mainly in intracellular tails. Microvillar projections at the cell surface
tend to be smoother with only the tips splaying outwards. In cases where projection tips do not
splay, the region of actin in contact with the virus particle shows a clear cup-like structure (Fig.
2). The same cup-like structure is seen in intracellular tails but is less pronounced (data not
shown).
For higher resolution studies using electron microscopy, we found that embedding the infected
cells as a monolayer after myosin S1decoration of the actin filaments and cutting sections
parallel to the plane of the cells yielded the clearest images (Fig. 3 and 4). Despite this, it was
difficult to obtain Perfect sections along the plane of the virus and tail. Consequently, the lengths
of tails observed in electron micrographs are shorter than in images obtained by fluorescence
microscopy, since thin sections cut through a complete actin tail from head to tip will occur very
rarely. However, the general overall apPearance of the actin tail in the electron micrcosoPe is in
good agreement with those in immunofluorescence microscopy (Figs. 3 & 4). In
electronmicrographs actin fIlaments in the tail splay outwards, as suggested by the branches seen
in fluorescence microsopy. This is especially evident in curled intracellular tails (Fig. 3). Thus
the tail apPears to be arranged almost like an "upside down Christmas tree" with the fIlaments
oriented so that they extend outwards from the centre of the tail.
Although a number of different fixation and cell Permeablization techniques were tried, it was
difficult to preserve the structural integrity of membranes, both those surrounding the virus and
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the plasma membrane, as well as the actin filaments. Consequently, the number of actin
filaments that are seen to directly interact with virus particles is lower than predicted in
comparison to the density of the tail immediately adjacent to the virus observed in
immunofluoresce images. However, actin filaments are clearly seen in contact with the
membrane around the vims particle (Figs. 3 and 4). In addition, when vims particles are
projecting from the cell surface, a number of actin filaments from the tail are seen in contact the
plasma membrane both in longitudinal (Fig. 4) and transverse sections (Fig. 5). From the
transverse sections it is clear that actin fl1aments interact with the plasma membrane both at their
fast-growing ends and along their lengths (Fig. 5). Electron micrographs of long projections
with withered bases clearly show that actin is still present along the whole length of the
projection, although at a much reduced density near the cell where they appear to be arranged in a
much more parallel fashion (Fig. 5).
Polarity and length of actin maments in the tail: Superposition of fl1aments over each other
in the same section within the bulk of the tail viewed by electron microscopy makes polarity
determination by myosin S1 decoration difficult. However, it is possible to discern the
characteristic myosin S1 arrowhead polarity on filaments towards or at the edge of the actin tails
in very thin sections (40-5Onm). In all cases the barbed or fast growing end of the actin
filaments point towards the virus (Fig. 4). Given that all filaments where arrowheads are visible
show the same polarity, we assume that the filaments within the bundle also share the same
polarity. As with fl1ament polarity detennination, it is difficult to measure the true length of
individual actin fl1aments within the tail. In our electronmicrographs we fmd filaments of up to
0.74 J.UIl, although this is probably an underestimation of the true length (Fig. 5).
Actin recnJitment to viral particles is polarized: The fact that the barbed ends of the filaments
point towards the virus particle suggests that actin monomers incorporate into tails at or near the
virus surface. To investigate if this was indeed the case, we adopted the technique of Symons
and Mitchison (1991), in which sites of actin polymerization are observed by the incorporation
of rhodamine labelled G-actin into cells which are permeabilized with saponin. Phalloidin
staining of uninfected cells permeablized with saponin confirmed that under conditions of our
assay, cells still maintained a highly organized actin cytoskeleton that incorporated rhodamine
actin into the leading edge, focal adhesions and stress fibres, even after 10 minutes of
permeablization (Fig 6).
A 10 second incubation of permeabilized infected cells with 1.0 J.lM rhodamine G-actin resulted
in incorporation of actin only at virus particles which had associated actin tails, but not into the
tails themselves which were visualised with phalloidin, i.e. total F-actin (Fig. 7). Only a
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proportion of virus particles recruited rhodamine actin, which is consistent with the proportion of
vims particles which induce tails (Cudmore, et al., 1995). There was no apparent difference in
the ability of vims particles to recruit rhodamine actin, whether they were on intracellular actin
tails or extending outwards from the plasma membrane on actin projections (Figs. 7 & 8).
Antibody labelling of virus particles together with rhodamine actin incorporation was used to
examine whether the pool of dynamic actin was polarized in its distribution on the vims surface
(Fig. 8). Both early and late incubation time-points actin recruitment onto the viral surface occurs
in a polarized fashion immediately adjacent to the tail.
Incorporation of actin into the tail occurs at a similar rate to motility: When the length of
incubation time with rhodamine G-actin was increased, incorporation of actin into the tail only
occurred from the virus particle which remained covered in a bright cloud of G-actin (Fig. 7 &
8). No rhodamine actin incorporation was observed along the tail that did not originate from the
virus particle, irrespective of incubation time. This observation suggests that the branch-like
structures which extend along the length of intracellular tails do not fonn by the addition of actin
monomers at their ends as they do not incorporate rhodamine actin from their tips. Although
there is some varation between cells, generally after 1 minute, rhodamine actin incorporation was
observed along 30-40% of the length of intracellular tails (Fig. 7). By 3 minutes the complete
length of intracellular tails were labelled with rhodamine actin (Fig. 7). Incorporation of
rhodamine actin into viral projections at the cell surface occurred at the same rate as that seen in
intracellular tails. EXPeriments Perfonned with 0.3 J.1M rhodamine actin, a value below the
critical concentration for assembly of actin at the pointed end, 0.7-0.9 J.1M in vitro, but above the
value of 0.1 J.1M for barbed end assembly, gave identical results with no qualitative difference in
the rate of incorporation. The rate of rhodamine actin incorporation into tails in the presence of
butanedione monoxime (BDM) was also indistinguible from control eXPeriments (data not
shown). BDM is a broad-spectrum inhibitor of the actin activated ATPase activity of non
muscle myosin fi, myosin V and probably most myosin isoforms (Cramer and Mitchison,
1995).
The site of actin incorporation becomes fragmented at the tip of projections: As figure 8
shows, the rhodamine actin incorporating structure in the virally induced projections from the
cell surface, i.e. the actin nucleating surface on the virus particle, tends to be cup-shaped.
However, in many cases these nucleating structures have fragmented into several foci, which are
still able to actively recruit rhodamine actin (Fig. 9). We also occasionally see projections that
are actively incorporating actin into these foci although there is no viral particle at the tip (data not
shown). The simplest explaination for our observations is that the actin nucleation sites are now
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present in the plasma membrane as a result of viral membrane fusion and are free to diffuse
within the plasma membrane. -.
DISCUSSION
The interactions between actin filaments and membranes is poorly understood. Previous
observations demonstrated that vaccinia vims is capable of inducing the formation of actin-rich
microvilli during its infection cycle (Hiller, et al., 1981, Hiller, et al., 1979, Krempien, et al.,
1981, Stokes, 1976). We have recently extended these earlier observations to show that the lEV
form of vaccinia induces the formation of actin tails that are similar to the actin tails seen in cells
infected with bacterial pathogens such as Shigella, listeria, and Rickettsia(Cossart, 1995,
Cossart and Kocks, 1994, Tilney and Tilney, 1993). The lEV form of vaccinia virus is
surrounded by a membrane cisterna derived from the trans Golgi network (Schmelz, et al., 1994
) and consequently it offers a unique opportunity to examine membrane-actin interactions in
detail. As a fmt step towards a detailed characterization of the system, we have examined the
structure and dynamics of the actin tail induced by lEV.
The ultrastructure oftbe vaccinia actin taU: Electron micrographs of both intracellular tails
and microvilli-like projections, show many features that are consistent with the
immunofluorescence images, suggesting that our fIXation and extraction process has not
drastically altered the structure of the tail. A common feature between the tails of vaccinia and
listeria is actin ftlament polarity. Although we cannot determine actin ftlament polarity in the
bulk: of the viral tail, both systems show that actin filaments at the edge of the tail have
unidirectional polarity, with their barbed or fast-growing ends in the direction of motion (Fig. 3).
Although similar in their polarity, we find that vaccinia tails contain longer actin filaments than
the O.2J.11l1length filaments reported in bacterial systems (Tilney and Portnoy, 1989). Given the
severe limitations for measurement from sections of actin tails, we suspect that the ftlaments
may be significantly longer. The most striking difference between the two systems is seen in the
organization of actin filaments in the tail. Actin filaments in vaccinia tails are oriented so that they
splay outwards at a 45° angle from the central axis of the tail. This is not the case in listeria tails
where fluorescence polarization microscopy shows that filaments in the core of the tail appear to
be randomly oriented, while those at the surface or shell of the tail are preferentially aligned
parallel to the direction of movement (Zhukarev, et al., 1995). This difference in structural
organization of actin filaments probably reflects a difference between the two systems in both the
nature of the actin nucleation site, as well as the actin cross-linking proteins in the tail.
Nucleation of actin taUs occurs asymmetrically at the viral surface: Under the conditions of
our penneabilization assay the actin cytoskeleton remains intact and readily incorporates
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rhodamine actin at leading edges and focal contacts. More importantly, the fact that actin tails
show progressive rhodamine actih incorporation suggests that viral particles are still moving in
our assay. From our results it is clear that the fIrSt stage of tail formation is the recruitment of G-
actin, and not pre-formed actin ftlaments, to the virus particle. Furthermore, continued tail
growth requires a constant recruitment of G-actin as viral particles remain coated in rhodamine
actin at all stages of incorporation experiments. We observe that actin nucleation occurs in an
asymmetric fashion on the vims particle surface, as is also observed for the bacterial comets
(Kocks, et al., 1993). We are currently unable to explain why actin recruitement is polarized on
the vims particle surface, given that the virus particle is covered in a membrane that has no
obvious asymmetry. However, the virus particle is asymmetric in shape and in our electron
micrographs, they are nearly always oriented with their long axes perpendicular to the tail.
Incorporation of rhodamine actin into the tail only occurs from the virus surface and not from
internal sites along the tail. Thus, actin branches on intracellular tails do not incorporate label
from their tips. This is an important observation as it suggests that the only free ends available
for polymerization of actin monomers are found at, or near the virus surface and that filaments
within the tail or branches are blocked from further addition of actin. We fmd that the rate of
incorporation is the same in intracellular tails and projections at the cell surface. Given that the
virus particle at the tip nucleates actin tail assembly, a constant supply of actin monomers must
be provided at the projection tip even when extentions are more than 20 J.1IIllong. Due to the
actin density within the tail, it is highly likely that the pool of actin is supplied by filaments
depolymerizing at the base of the tail. We also find that the rate of incorporation of rhodamine
actin is the same regardless of whether it is used above or below the critical concentration for
assembly of actin at the pointed end in vitro. Hence polymerization only occurs at the free barbed
ends found at the virus particle surface, in agreement with filament polarity.
Movement of the viral particle is driven by actin polymerization.
Elegant photoactivation experiments have shown that the rate ofUsteria motility is proportional
to the length of the tail (Theriot, et al., 1992). Furthermore, this rate is equal to the rate of actin
filament growth at the bacterial surface suggesting that motility is driven by continuous
polymerization and release of actin filaments and that mysoin motors are not involved (Theriot,
et al., 1992). To date myosin has not been identified in the tail of any bacterial pathogen by
immunofluorescence microscopy. We have previously shown that vaccinia moves at a rate of
2.8 J.LIDImin (Cudmore, et al., 1995). Ifvaccinia virus moves by a similar mechanism, bksed on
this average speed we would expect that tails of length between 6.4-9.6 J.1IIl would show 100%
rhodamine incorporation in about 2.5-3.0 minutes. This calculation is consistent with our
observations. Thus, qualitatively the rate of actin polymerization at the virus surface is equal to
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its rate of movement, suggesting that actin assembly alone can generate vaccinia motility. Our
BDM inhibition experiments, although not conclusive as it is not known whether BDM inhibits
all myosin isoforms, are extremely suggestive that no myosin motor is involved in the motility
process. This is not unexpected as based on the organization of myosin and actin in muscle, the
actin ftlament polarity in the tail is incompatible with a myosin driven motility.
Given that a similar mechanism of actin polymerization drives the motility of vaccinia and
bacterial pathogens, why are their rates of motility so different? We have measured vaccinia
motility as 2.8 J.1IDImin whereas values for Listeria between 6-60 Jlmlmin can be found in the
literature (Cossart, 1995, Dabiri, et al., 1990, Theriot, et al., 1992). It is known that the rate of
motility in Listeria is proportional to the tail length and we assume that the same holds tnle for
vaccinia. Therefore, using the data in Theriot et al., ( ~1 ! 1992) with a tail length
distribution of 6.4-9.6 J.1.1Il for vaccinia we would expect viral particles to move at 12-16
J.1IDImin. The fact they do not suggests that other factors are important. Clearly, density of actin
filaments will be an important detenninant in the rate of movement. From our observations it is
clear that actin ftlaments in the vaccinia tail are extremely dense and at least as dense as those in
Listeria tails (compare Figs. 3-5 with Figs. 16 and 17 (Tilney and Portnoy, 1989) and Fig 4B
(Kocks, et al., 1992». The shape of the particle being propelled by the actin tail may play an
important determining factor. However, the rate of movement of E.coli expressing IcsA from
Shigella flexneri in Xenopus egg extracts shows a similar range of speeds irrespective of whether
their long axis is parallel or perpendicular to the direction of movement (Goldberg and Theriot,
1995). Given that the shape of the object does not seem to effect the rate of movement, why
then if vaccinia particles are smaller than bacteria and presumably easier to move through the
cytoplasm are the rates of movements not similar? We would like to suggest that a large
determining factor is the difference in actin ftlament organization between the two systems.
However, the molecular mechanisms responsible for these differences must be addressed by
more detailed analysis.
Transfer of viral-actin nucleation sites to the plasma membrane: One feature that was
noticeable in rhodamine actin incorporation experiments was that in long projections emerging
from the plasma membrane actin incorporation sites were often fragmented into several foci
(Fig. 8). In the most extreme cases, the incorporation of rhodamine actin occured at the tips of
these foci. We would like to suggest that these foci originate when the outer membrane of the
lEV fuses with the plasma membrane to release the BEV, the second infectious form of vaccinia
vims (Fig. 10). Such a fusion event would transfer actin nucleation sites from the membrane
around the lEV to the plasma membrane where nucleation appears to continue, despite the fact
that the particle is now localized on the outerside of the plasma membrane (Fig. 10). In support
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of this hypothesis we often see vints particles which apPear to be on the outside of microvillar
projections, suggesting that they have already fused with the plasma membrane (Fig 3A). That
these particles are indeed EEV, can be confmned by conventional thin section electron
microscopy analysis under conditions that avoid cell Permeabilization (data not shown). A
similar conclusion can be drawn from images in the original high voltage microscopy study of
vaccinia virus release by Stokes (Stokes, 1976). Consistent with this, it has previously been
reported that the lEV is released from the cell by fusion of its outer membrane with the plasma
membrane, releasing the EEV (Blasco and Moss, 1991, Blasco and Moss, 1992, Dales, 1971,
Ichihashi, et al., 1971, Morgan, 1976). However, some of the BEV can remain attached to the
outer surface of the cell, these being refered to as CEV (Blasco and Moss, 1991, Blasco and
Moss, 1992). It has been proposed that while the BEV is responsible for long range spread of
virions (Appleyard, et al., 1971, Boulter and Appleyard, 1973, Payne, 1980), that the role of the
CEV is in direct cell to cell spread (Blasco and Moss, 1992). We believe that the virus particles
on the outer suface of projection tips are CEV and thus actin polymerzation provides the
mechanism by which these particles contact neighbouring cells in order to cause the direct cell to
cell spread of infection.
Conclusions: Actin ftlaments at the leading edge of motile cells are not organized Perpedicular
to the plasma membrane but rather in an orthogonal network at an angie of 450 (Small, et al.,
1995). It is striking that the organization of actin ftlaments nucleated from the membrane
surrounding vaccinia virus is very reminiscent of the leading edge, both in organization and
polarity. Given the parallels between the two systems we believe that a detailed understanding of
the interaction between the nucleating complex in the outer membrane of vaccinia virus and actin
filaments will provide further insights into actin-membrane interactions at the leading edge of
motile cells.
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FIGURE LEGENDS
Figure 1: Overall appearance of vaccinia infected cells by immunofluorescence microscopy.
Panels A and B show entire cells containing numerous actin tails which were fIXed at 8h and 16h
post infection respectively. The higher magnification images, C and D, show long projections
from the cell surface with withered bases as well as shorter, newly fonned projections. Such
long projections are often observed to be over 20J.1IIl in length. Scale bar in B represents 25J.1IIl
in panels A and B while that in D represents 20J.1IIl in C and D.
Figure 2: High resolution images of intracellular tails and projections stained with phalloidin.
A and B show branch like structures splaying outwards from intracellular tails. Panel C shows
that the region of the actin tail in contact with the virus particle has a cup-like shape. Virus
particles lie at the broader, more brightly stained end of the tails. Scale bar represents 3J.1IIl in all
panels.
Figure 3: Electron microscopy of S1 myosin decorated intracellular tails. Panel A shows a
highly curled tail with filaments splaying outwards at a 45° angle to the central axis of the tail.
Panel B shows two intracellular tails with actin filaments interacting directly with the virus
particles. Note that the virus particles are oriented with their longer axes perp lldicular to the long
axis of the tail. Stars indicate virus particles. Scale bars represent 4OOnm.
Figure 4: Electron microscopy of virally-induced projections. In panel A the polarity of the S1
myosin decorated actin filaments can be discerned and is indicated by closed arrowheads. The
barbed or fast-growing end of the filaments are oriented towards the virus particle. Interactions
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between individual actin fl1aments and the plasma membrane are indicated by open arrowheads.
The virus particle, labelled by the star, appears to be outside the plasma membrane. The length
of a single fIlament, 44Onm, is indicated. Panel B shows another projection where the virus
particle still appears to be inside the plasma membrane. Scale bars represent 400nm.
Figure 5: Electron microscopy of vaccinia induced projections, both longitudinal and
transverse sections. A shows a long projection that lacks a virus particle at its tip. Membrane
interactions with actin filaments are indicated by open arrowheads and a single long actin
filament is also indicated. The density of actin filaments at the base of the tail is clearly reduced
in comparison to the top. In addition, the fl1aments in the base tend to have a more parallel
arrangement than at the top of the tail. B shows a transverse section through the top of a
projection. The density distribution of actin filaments is consistent with longitudinal sections.
Two orientations of actin filaments interacting with the plasma membrane are discemable: open
arrows indicate examples where filaments ends are in contact while closed arrows show
filaments interacting along their length. Scale bars represent 4OOnm.
Figure 6: IncorPOration of rhodamine actin into permeabilized cells shows that actin
cytoskeleton of an uninfected cell is both stable and dynamic after 10 minutes of
permeabilization and incubation with exogenous rhodamine actin: A, the complete actin
cytoskeleton visualised by biodipy phalloidin; B, localization of rhodamine actin incorporation
sites and C, merged false colour images of phalloidin (green) and rhodamine actin images (red)
showing that although focal contacts have incorporated rhodamine actin, they also maintain a
pool of uninCOrPOrated G-actin at their tips. Scale bar 20 J.UD.
Figure 7: IncorPOration of rhodamine actin into vaccinia actin tails occurs from the viral
particle surface. Panels A, D, and G: total F-actin visualised by phalloidin; panels B, E and H:
localization of rhodamine actin after 10 seconds, 1 minute and 3 minutes respectively. Panels C,
F and I: merged false colour images of the phalloidin signal (green) and the rhodamine signal
(red) for A & B; D & E and G & H respectively. From the images in the figure it is clear that
viral particles recruit rhodamine G-actin to their surface which then becomes incorPOrated into
the tail. After 10 seconds only virus particles are labelled with rhodamine G-actin but after 1
minute the rhodamine signal is seen about half way down the tail when compared to the
phalloidin signal. After 3 minutes, rhodamine actin has incorPOrated down the complete length
of the tails as judged by the rhodamine and phalloidin signals. In all merged panels it is
noticeable that there is not 100% co-Iocalization between the rhodamine signal on the virus
particle and the phallodin signal of the tail suggesting the virus maintains a pool of G-actin on its
surface. Scale bar 9 J1Dl.
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Figure 8 : Rhodamine actin incorporation combined with antibody labelling of virus particles.
Panels A and D show virus particles while B and E show rhodamine actin incorporation after 10
seconds and 3 minutes respectively. C and F show merged false colour images of the virus
particles (green) and the rhodamine signal (red). White arrows in the merged images highlight
that there is not 100% co-Iocalization of the viros particle and rhodamine signals indicating G-
actin is recruited in a polarised fashion to the virus particle surface. Scale bar 8 J.1IIl.
Figure 9: Actin nucleation sites at the projection tips fragment into foci. Panels A and D show
rhodamine actin incorporation after 3 minutes. Panel B shows total F-actin visualised by biodipy
phalloidin and panel E shows labelling of virus particles. C and F show merged false colour
images of the rhodamine signal (red) and phalloidin or virus signal signal (green) for A & B and
D & E respectively. White arrows in A to C indicate a branch near the tip of a projection
incorporating rhodamine actin i.e. nucleating actin polymerization. White arrows in D to F
highlight the fragmentation of the actin nucleating surface at the tip of a projection into discrete
foci, many of which are not in contact with the virus particle. Scale bar 7 JlIIl.
Figure. 10: Model depicting the development of virally induced microvilli and fusion of the
outer membrane of the lEV with the plasma membrane at the tip of this projection. The plasma
membrane is shown in green and actin ftlaments in the projection are blue. The lEV is shown in
black with its outer most membrane depicted in red. In panel A, the actin nucleation sites present
in the viral membrane nucleate actin polymerization and consequently the projection extends
outwards. B. The outer most membrane of the lEV form of vaccinia (red), along with its actin
nucleation sites, fuses with the plasma membrane, releasing the CEV outsice the projection
ready to infect neighbouring cells upon contact. C. The actin nucleation sites, which are now
present in the plasma membrane, begin to diffuse but still continue to nucleate actin filaments as
the projection extends.
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Discussion
5.1 What has been learnt from this work?
As most of the details of my work have been discussed at the end of the various
chapters, I would like to present a review of the various assembly stages of vaccinia virus in
relation to what has been learnt from both my research and the recent work of others. An
updated version of the lifecycle is presented in figure 8, while a cartoon of the IMV structure
is shown in figure 9.
5.1.1 Reyiew of the vaccinia life-cycle
Vaccinia DNA is replicated in the cytoplasm of the infected host cell in specialised
foci called "viral factories" (Cairns, 1960), which are observed close to the nucleus by
immunofluorescence microscopy, when stained with DNA dyes such as DAPI or Hoechst.
About 4 hours after infection late protein expression begins and infected cells can be labelled
with antibodies to a variety of these viral proteins, including p35 (gene H3L) (Cudmore et
al., manuscript in preparation), p32 (gene D8L) (see appendix for Sodeik et al., 1995), p39
(gene A4L) (chapter 2) and p21 (AI7L) (Krijnse Locker et al., submitted). This labelling
overlaps with that of the DNA but the signals do not co-localize completely (Sally Cudmore
and Jacomine Krijnse Locker, unpublished observations) (Sodeik et al., 1994) suggesting
that there are two distinct regions involved in the early steps of DNA replication and late
protein expression. This was especially apparent when cells were labelled with antibodies
against p39 (chapter 2), p35 (Cudmore et al, manuscript in preparation) or with antibodies
against vaccinia core proteins (Krijnse Locker, unpublished results). The labelling of the
protein factories occurs in distinct patches while the immunofluorescence staining of the
DNA is more diffuse. These separate areas are also morphologically distinct by electron
microscopy, with the protein factories apparent as electron dense areas close to the nucleus,
while antibody labelling of the DNA indicates it is located in a more disperse pattern in the
cytoplasm (Sodeik et al., 1993). There is no trace of DNA labelling in the protein factories,
but it cannot be ruled out that this is not due to a problem of antibodies access in these
factories. The distinction becomes even more obvious when cells are infected in the
presence of rifampicin, which blocks viral assembly subsequent to DNA replication and
protein expression (see section I.S). Large electron-dense areas called "rifampicin bodies"
accumulate in the peri-nuclear region of the cell which are composed of viral proteins (Payne
and Kristensson, 1990) and are probably equivalent to the protein factories. Other structures,
called inclusion bodies, have also been observed and shown to label with antibodies against
p65, the target of rifampicin (see section 1.5) (Sodeik et al., 1994). The replicated DNA
tends to accumulate in large striated structures, sometimes called "DNA crystalloids".
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Therefore in figure 8, I have moved away from the more traditional name of "viral factory"
and have referred to these separate areas as (i) the "DNA factory", where the DNA
replication occurs and (ii) the "protein factory", where the proteins accumulate after
translation. Thus the DNA is replicated and transcribed in the DNA factories using enzymes
encoded by the vaccinia genome, and the functional mRNAs are subsequently translated by
the host cells normal protein translation machinery and then accumulate in the protein
factories. Vaccinia infection causes a rapid inhibition of cellular protein synthesis, partially
by inducing the degradation of host cell mRNA (Rice and Roberts, 1983), and by diverting
the protein synthesizing machinery to the exclusive production of viral polypeptides (Moss,
1968; Shatkin, 1963).
From electron micrographs it appears that the protein factories are surrounded by
membranes (Sodeik et al., 1993, 1994). As maturation continues, these membranes begin to
bud out and become rigid and spherical-shaped, most likely due to the presence of viral
membrane proteins, as well as peripheral proteins. Indeed, it has been shown that a number
of viral proteins are associated with these "crescents", many in a polarised fashion, i.e., they
are preferentially associated with one membrane, e.g. p65 (gene DI3L) is peripherally
associated with the concave surface (Sodeik et al., 1994), p21 (gene AI7L) is an integral
membrane protein of the inner membrane (Krijnse Locker et al., submitted) , while both p35
(gene H3L; Cudmore et al., manuscript in preparation) and p32 (D8L) (see appendix for
Sodeik et al., 1995) are membrane proteins of the outer membrane of the crescents. p14,
although not present in the crescents, is peripherally associated with the external face of
outer membrane of the IMV (see appendix, Sodeik et al., 1995).
The membrane proteins of the IMV are quite unusual in that, to date, only one protein
has been shown to be a typical membrane protein. p21 (AI7L) is translocated across the
endoplasmic reticulum membranes in a normal co-translational fashion and subsequently
targetted to the intermediate compartment (Krijnse Locker et al., submitted). The other
membrane proteins, p32 and p35, have their putative membrane spanning sequence in the C-
terminal region of the protein, indicating that co-translational membrane insertion most
likely does not occur (Cudmore et al., manuscript in preparation; Niles and Seto, 1988). The
proteins which are targetted to the IC membranes surrounding the protein factories are
involved in shaping the now developing "viral membranes". The fact that these two
membranes are so tightly apposed to each other (Sodeik et al., 1993; Krijnse Locker et al.,
submitted; see appendix for Roos et al., 1996) implicates the presence of protein(s) which act
to link them in some way (see section 5.2.1). Other viral proteins, those which are not
integral membrane proteins, are most likely syntheized on free ribosomes and become
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associated with the virions as part of the "viroplasm". In the case of p39 (A4L), this is most
easily explained by the possible interaction ofp39 with an integral membrane protein(s) in
the inner membrane of the developing "viral crescents". One candidate for such an
interaction is p21 (AI7L) (see chapter 2)
Once the DNA is replicated, it appears to be assembled into specific sized
"allotments" which are approximately 35nm in length when observed by electron
microscopy (Gareth Griffiths, unpublished observations). These small DNA packages are
most likely equivalent to one genome. They have obvious striations in one direction, the
longer axis. A similar observation was made in cells infected in the presence of rifampicin,
but in this situation the DNA accumulates in large structures, sometimes referred to as "DNA
crystalloids", and again the striated appearance is obvious. Analysis of the diffraction
pattern obtained from electron micrographs of these DNA crystalloids indicated that the
striations occur with a repeat of approximately 25A (Vincent Guenebaut and Sally Cudmore,
unpublished observations). As DNA helices (of the B-DNA form which is normally found
in bacterial and eukaryotic genomes) have a diameter of 23.7A, this strongly suggests that
vaccinia DNA parcels are packaged into the developing IVs in a naked fashion, that is, there
are no proteins associated with the DNA. This is consistent with extensive labelling studies
as there is never any labelling of these structures, or the DNA crystalloids which form in
rifampicin treated cells, by any antibodies against vaccinia proteins (Sally Cudmore, Maria
Ericsson, Beate Sodeik, Sibylle Schleich and Jacomine Krijnse Locker, unpublished
observations)
Once the DNA is packaged, the virions appear to undergo a number of morphological
rearrangements, as the IV matures to the IMV. These two distinct assembly stages of
vaccinia differ in both their composition and morphology. The IV, which has not yet
packaged its quota of DNA, is spherical in shape. By electron microscopy, it appears to have
a single membrane profile but when treated with proteinase K prior to fixation, it is apparent
that this single membrane profl1e is, in reality, two membrane bilayers (Sodeik et al., 1993).
During maturation to the IMV, a new "core-like" structure forms, which appears to surround
the recently packaged DNA. The IMV, in contrast to the IV, has two apparent membrane
profl1es when viewed by electron microscopy. One of these is the "core-like" structure
which surrounds the DNA, while the other profl1e represents the membrane surrounding the
IMV. It has been hypothesised that these two visible membrane profl1es are qualitatively the
same as those of the IV, with the inner membrane bilayer having collapsed to form the core
structure which surrounds the DNA (Sodeik et al., 1993; see also appendix for figure 2b,
Roos et al., 1996). This would mean that p39 would be located within the core. However,
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this is not the case and due to the localization of p39 between the core and the surrounding
membranes, it is more likely that outer membrane profIle represents the two membranes of
the IV and that the profIle surrounding the DNA, the core structure, forms within the virion
during maturation to the IMV (chapter 2) (see appendix for fig 2a, Roos et al., 1996) .
Other structures, whose appearance coincides with that of the core, are the spike-like
protrusions which extend between the core and the surrounding membranes of the IMV.
These are 200m structures, frrst described by Dales (1963) and later observed by
cryomicroscopy by Dubochet et ale (1994). These spikes probably function as a link
between the core and the surrounding membranes. In chapter 2 of this thesis and in Roos et
ale 1996, it is proposed that these spikes are composed, at least in part, by p39 (gene A4L).
The EEV has been described as the infectious form of vaccinia which is responsible
for long range spread of virus in vivo (Appleyard et al., 1971; Boulter and Appleyard, 1973;
Payne, 1980), while then CEV is thought to be responsible for the direct cell-to-spread
(Blasco and Moss, 1991; Blasco and Moss, 1992). It is likely that these enveloped viral
forms are the most important for the in vivo spread of the disease, as a clear and independent
role for the IMV has not been established. It has been shown previously that actin is
involved in the release of vaccinia virus (Hiller et al., 1981; Hiller et al., 1979; Krempien et
al., 1981; Stokes, 1976). In chapter 3, I have elucidated the manner in which vaccinia moves
through the cytoplasm of the host cell in an actin-based manner by inducing the formation of
actin tails which are anchored in the cell, thereby pushing the virus particle forwards. I also
demonstrated using a combination of drug and mutant studies that it is the lEV, the precursor
of the second infectious form, which moves within the cell. Therefore, I have proposed that
this mechanism of actin-based microvilli protrusion is the means by which CEV is presented
to neighbouring cells. In chapter 4, it is hypothesised that the outer membrane of the lEV
fuses with the plasma membrane during the extension of the microvilli, giving rise to a CEV
at the tip of the projection. It is also noticeable that a greater number of virally induced
projections are seen extending from the surface of the infected which is closest to a
neighbouring cell (unpublished observations). This suggests that the infected cells are able
to sense the presence of a neighbouring cell, in order to direct virus particles in this manner.
Due to the fact that vaccinia is exposed at the tip of the projection, the virus can still enter a
neighbouring cell by fusion of its outer membrane with the plasma membrane of the
neighbouring cell, the currently accepted model of vaccinia entry (Doms et al., 1990) and
does not necessarily invoke the need of either endocytosis or phagocytosis. This mechanism
of entry is different to the bacterial pathogens which remain inside the tip of the extension,
and are subsequently phagocytosed, still within the projection.
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5.2 Future Questions
5.2.1 Structure of the !MY
As discussed in chapter 2, p39 (gene A4L) interacts with the viral membranes
surrounding the IMV, without having any hallmarks of being a membrane spanning protein
itself. Therefore, the association with membranes must be achieved through an interaction
with an integral membrane protein(s) in the inner membrane of the IMV. What is the
identity of this protein ? To date, only one protein has been preferentially localized to this
inner membrane, p21 (gene A17L) (Krijnse Locker et al., submitted). This is an essential
protein, which if deleted prevents crescent formation (Rodriguez et al., 1995). p21 is co-
translationally inserted into the endoplasmic reticulum and is subsequently targetted to the
intermediate compartment where it plays a role in the development of the crescent shaPed
membranes, which are the progenitors of the IVs (Krijnse Locker et al., submitted;
Rodriguez et al., 1995). The co-immunoprecipitation eXPeriment in chapter 2 suggests that
p39 may interact with p21, thereby being responsible for the strong membrane association
demonstrated by p39 in biochemical assays. As p21 is already present in the membranes
surrounding rifampicin bodies and a significant proportion of p39 is also found associated
with these membranes, it further strengthens the possibility that p21 could act as a membrane
anchor for p39. p21 is predicted to span the inner membrane 4 times with both termini
present in the space between the membranes and the viral core (Krijnse Locker et al.,
submitted). This topology results in three regions of the protein being candidates to interact
with p39, the N-terminal61 amino acids, the loop region between amino acids 98 and 118
and the C-terminal region (see figure 9).
Another question which awaits answering is the identity of the spike between the
core and the membranes of the IMV. In chapter 2 and in Roos et al, (1996, see apPendix), it
is postulated that p39 may comprise part of this spike. If this is the case, it is likely that
another protein(s) is also involved as p39 does not form homo-oligomers, at least in vitro,
and alone is not large enough to form structures of 20nm in length. Other potential proteins
could be the core proteins 4a, 4b, pll and p25 (see section 1.4.1 and references therein).
The membranes of the IV and IMV are tightly apposed and therefore it is likely that a
membrane protein(s) acts to keep them so tightly associated (figure 9). This protein(s) could
be present in either or both membranes, but would probably need to have a significant
proportion present in the lumenal space between the membrane bilayers in order to interact
with either itself or other proteins.
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5.2.2 vaccinia-actin motility: future directions
Bacteria do it, and the results presented in chapters 3 and 4 demonstrate that viruses
can do it too! Therefore, two extremely diverse tyPes of intracellular pathogens can
commandeer the actin cytoskeleton of their host cells and rearrange it in a manner which
enables them to move both within the cell, and to form projections which facilitate their
direct spread from cell-to-cell. But is this phenomenon restricted to vaccinia virus or are
there other, as yet undetected, viruses which move in a similar manner? An even larger
question: if extracellular pathogens induce motility such as this, is it not possible that
intracellular organelles do the same? In other words, could actin nucleation and
polymerization from membranes surrounding intracellular organelles provide a general
mechanism of motility within cells. There is a small amount of evidence which suggests that
this may not be as bizarre and outlandish as it seems.
Work by Heuser and Moriaski (1992, Mol. Cell. BioI. 3., 172a) demonstrated that
actin polymerization is also involved in the propulsion of endosomes to and fro in the cell, in
apparently random trajectories. This is observed after the application of lanadium followed
by zinc, and this "phenomenon bears a striking similarity to the rocketing motility displayed
by Listeria..." Thus the authors hypothesized that "organelle propulsion via actin
polymerization or rocketting may playa normal role in delivering organelles to more
directed microtubule-based trafficking pathways, and possibly, may be a mechanism to
initiate segregation and processing of endosomal contents".
Though not often discussed, when using Xenopus egg extracts to reconstitute in vitro
motility of bacteria (Theriot et al., 1992), the extracts alone also form actin tails which
apPear to elongate in a similar fashion to the bacterial tails. For the work with bacteria, this
problem was generally overcome by the addition of TX-100 which disrupts the endogenous
membrane vesicles which are responsible for tail formation l . The fact that TX-l00
disrupted the endogenous vesicles which caused the actin tails, suggests that the factor
inducing the formation of the actin assemblies in the absence of bacteria is membrane
associated. It is thought that this factor may be a component of the egg cortex (Michael
Glotzer, personal communication). In my attempts to establish an in vitro motility assay for
vaccinia, it was not possible to use TX-100 as this also disrupted the membranes surrounding
the virions and therefore work is continuing to attempt solving this problem.
1 The only paper where this is actually mentioned, to the best of Illy knowledge, is Marchand et al., 1995.
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What viral factors are involved in this actin assembly process? A number of
interacting components have been described for bacteria which are essential for their
motility. These include the bacterial expressed membrane proteins, Act A in listeria
monocytogenes (Domann et al., 1992; Kocks et al., 1992), Ics A in Shigella (Bernardini et
al., 1989) and Iact A in Listeria ivanovii (Gouin et al., 1994). Act A in tum has been shown
to interact with a cellular component, VASP, which in tum can bind to an actin-sequestering
protein, profl1in (for a review see Pollard, 1995). Hence another interesting question will be
to find the viral and cellular factors involved in vaccinia motility. As was shown in chapter
4, the recruitment of actin to the virus appears to occur in a polarised fashion as actin is often
observed in a cup-shaped distribution surrounding the virus particle at the earlier stages of
tail formation. What factor is responsible for this polarised assembly of actin? Another
interesting point is that the actin tails induced by vaccinia are almost exclusively seen to be
at right angles to the long axis of the virus particle, in contrast to the bacterial tails which
form prepindicularly to short axis. This means that the actin tail is pushing the longer viral
surface through the cytoplasm and one would imagine that this would be more inefficient
due to the greater friction. However, the larger surface area which is available to cause actin
polymerization is sufficient to outweigh this problem of drag.
Vaccinia encodes a protein which is 31.8% identical to human profilin, but as yet a
function has not been established for this protein, and it certainly is not essential for the
actin-based motility as profilin deletion mutants still move (chapter 3). Whether cellular
profilin plays a role is unknown, but a protein which would facilitate the recruitment of actin,
is probably necessary. It is very likely that a membrane protein in the lEV is be involved in
the process, either directly or indirectly recruiting actin to the membrane. One possible
candidate, due to both its abundance and the fact that the protein is cytoplasmically exposed
in the lEV, is p37 (gene FI3L, see section 1.4.3). Another potential viral player is the
protein product of the gene FSL. This is a 65 amino acid protein which has not yet been
identified or functionally characterized, but its sequence shows a very low amount of
homology to Act A in that it also has a number of proline residues. A knockout of FSL is
currently being engineered to elucidate if this protein plays a role in the motility process
(Sidney Higley and Michael Way, personal communication). It also remains to be
established if host cell proteins such as VASP, or other cellular protein(s), also participate.
Our current understanding of the interactions between the actin cytoskeleton and
membranes is rudimentary. Could vaccinia virus provide a means by which to study the
complex interactions between membranes and actin? The outer membranes surrounding the
lEV are derived from cisternae of the trans Golgi network, and it is these membranes which
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drive the nucleation and polymerization of actin, probably through the mediation of a virally-
encoded, TGN targetted, membrane protein. Upon reaching the plasma membrane another
set of complex membrane interactions take place and the actin-tail behind the virus particle
drives the formation of a projection from the cell surface. As is clear from chapter 4, the
actin in these projections interacts with the surrounding plasma membrane. Very little is
known about the mechanisms of microspike protrusion in ordinary cells or about the
interactions which occur between the actin and the membranes, especially at the tip of the
microspikes where the addition of actin monomers is thought to playa key role in the
extension of these structures.
Thus the in vitro permeabilized cell system used in chapter 4 2 should provide a
means to further investigate the key components involved in the actin-based motility of
vaccinia virus.
2 This is the first time that such a permeabilised cell system has been used to observe particles or organelles
moving within cells.
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ABSTRACT
We introduce a novel approach for combining immunogold labelling with cryoelectron
microscopy of thin vitrified specimens. The method takes advantage of the observation that
particles in suspension are concentrated at the air-water interface and remain there during the
subsequent immunogold labelling procedure. Subsequently, a thin aqueous film can be formed
that is vitrified and observed by cryo EM.
In our view a key early step in the assembly of vaccinia virus, the formation of the spherical
immature virus, involves the formation of a specialized cisternal domain of the intermediate
compartment between the endoplasmic reticulum and the Golgj. Using this novel cryoelectron
microscopy approach we show that in the intracellular mature virus (IMV) the core remains
surrounded by a membrane cisterna that comes off the viral core upon treatment with
dithiothreitol, exposing an antigen on the surface of the viral core. Complementary protease
studies suggest that the IMV may be sealed not by membrane fusion but by a proteinaceous
structure that interrupts the outer membrane. We also describe the structure and membrane
topology of the second infectious form of vaccinia, the extracellular enveloped virus and confmn
that this form possesses an extra membrane overlying the IMV.
INTRODUCTION
The classical view of the assembly of poxviruses such as vaccinia was that it involved a de novo
synthesis of a single viral membrane in the cytoplasm (Dales and Mosbach, 1968). This
assumes that the membrane arranges itself to build the fIrSt, morphologically distinct form of the
assembling vitus, the spherical immature vinls (IV). The IV then encloses the viral DNA and
develops further into the fIrSt infectious form, the brick-shaped, intracellular mature vinls (IMV),
previously referred to as the intracellular naked vitus (reviewed by Dales and Pogo, 1981).
We have recently challenged this classical view and argued that both the IV and IMV possess
two distinct, but tightly-apposed membranes, a consequence of their being derived from a
specialized domain of the ER, the intermediate compartment (Sodeik et al., 1993; Krijnse-Locker
et al., 1994). Although the presence of two tightly apposed membranes in the IV is difficult to
show without using protease treatment, two distinct membrane profiles are visible in EM
sections of the IMV using both thawed cryosections of fixed cells and epoxy resin sections
(Dales and Pogo, 1981; Sodeik et al., 1993). This poses a dilemma (see below).
Whereas the IMV is not found in appreciable amounts in the extracellular medium of infected
cells (except, presumably upon cell death), the extracellular enveloped viros (EEV) is actively
released from the cell (Appleyard et al., 1971; Payne and Normy, 1978; Payne 1978). In the
process of EEV assembly, the IMV acquires two additional membranes derived from the trans
Golgi network (TON) cisternae forming an intracellular enveloped viros (lEV) that possesses
four distinct membrane profiles in thin sections (Hiller and Weber, 1985; Schmelz et al., 1994).
This second, cisternal envelopment of the IMV is critically dependent on at least two membrane
or membrane-associated proteins; i.) a 14 kD protein on the surface of the IMV (Rodriguez and
Esteban, 1987; Rodriguez and Smith, 1990; Sodeik et al., 1995) and, ii.) a 37 leD palmitylated
protein in the cisterna derived from the TON , which behaves as an integra} membrane protein
(Hiller and Weber, 1985; Schmutz et al., 1991, 1995) (Table 1). Two other integral membrane
proteins of the wrapping cisterna, p21 and p42-SO are seemingly also essential for the formation
of the four-membraned lEV (Duncan and Smith, 1992).
According to the available data, the lEV fuses with the plasma membrane, releasing the three-
membraned EEV into the extracellular medium (Payne and Kristenson 1979; Hiller et al., 1981;
Schmelz et al., 1994). The movement of the lEV through the cell in order to reach the plasma
membrane is caused by the formation of filamentous actin tails behind the vinls particles. These
actin tails closely resemble the structures first described for Shigella bacteria (Clerc and
Sansonetti, 1987). On reaching the plasma membrane, the viros particles project outward from
the cell at the tip ofvirally-induced actin microvilli (Cudmore et al., 1995). Following exocytic
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fusion the released EEV particles expose the lumenal domains of the EEV-specific spanning
membrane glycoproteins. It is not yet clear whether any part of the 37 leD protein is also exposed
on the EEV surface, but it is predicted (and recently shown; Schmutz et al., 1995) that the major
part of this protein would be cytoplasmically disposed, both on the plasma membrane (after lEV
fusion) and in the space between the EEV outer and inner membranes. Since both infectious
forms of vaccinia, the IMV and the EEV (that has one additional membrane relative to the IMV
) are both thought to enter the cell by fusing with the plasma membrane of the host cell (Ooms et
al., 1990), one has to assume that two different mechanisms of viral disassembly are employed.
When the IMV infects cells it appears to release the viral core into the cytoplasm (Dales, 1963)
where the early transcription machinery present in the viral core is activated. This event can be
reconstituted in vitro (Kates and McAuslan, 1967). However, if the EEV fuses with the plasma
membrane during infection it will seemingly put an intact IMV particle into the cytoplasm. The
question therefore arises, how can an IMV particle previously assembled in the cytoplasm of an
infected cell be disassembled in the cytoplasm of the cell it infects?
The novel technique developed during this study was to combine cryoelectron microscopy with a
colloidal gold based immunolabelling procedure which was then used to investigate the structure
of purified fractions of both the IMV and EEV. For the IMV a preliminary cryoelectron
microscopic study has already been described (Dubochet et al., 1994). Two significant fmdings
were reported in the latter publication; i.) the images of the IMV confirmed earlier data based on
chemically-fixed material and showed two membrane-like domains that were separated by a
layer of spike-like structures and, li.) upon treatment of the IMV with NP40 and dithiothreitol
(DTT), a treatment extensively used to prepare biochemical amounts of viral cores (Easterbrook,
1966; Holowczak and Joklik, 1967), the ensuing particles were covered by an array of spike-like
projections morphologically similar to structures frrst described in conventional Epon sections in
both the IV and IMV by Dales and Siminoviteh (1961) and Dales (1963). Beneath this palisade
of "spikes", an electron dense layer is seen.
Two different models can be envisaged to account for the observed features (Fig. 1). First, the
two bilayers of the IMV seen in both conventional EPON sections and by cryo EM are the result
of a separation of the two tightly apposed IV membranes (Fig. 2, model B). In this case the inner
of these two membranes will constitute the core "membrane". Alternatively, the outer
"membrane" of the IMV is, as in the IV, composed of two tightly apposed membranes (Fig. 2,
model A). In that case the distinct core "membrane" must be additionally accounted for. One of
our major goals at the outset of this study was to distinguish between these two models.
Cryoelectron microscopy of thin ftlms of vitrified suspensions is by far the most suitable
method for observing delicate biological particles for high resolution electron microscopy::.- ___
(Dubochet et al., 1988). In most cases it helps to overcome the usual preparation arte etM~
~~
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chemical fIXation, staining and dehydration. In this method a drop of suspension is applied
directly to a grid or a grid coated with a perforated carbon film. It was found recently that
particles suspended in the solution tend to adsorb to, and concentrate at, the air-liquid interface in
the holes of the grid (Johnson and Gregory, 1993). Most of the drop of suspension can be
replaced by other buffers without loss of the particles adsorbed at the surface (Cyrldaff et al.,
1994). These adsorption properties allow one to perfonn chemical treatments, staining and/or
immunolabelling of the adsorbed particles under extremely mild conditions. Finally most of the
drop is removed with a blotting paper and the residual thin layer containing the treated particles
can be vitrified and observed in the cryoelectron microscope.
In the present study we have taken advantage of this observation in order to combine chemical
treatment, uranyl acetate staining and immunogold labelling, employing a spectrum of
antibodies, with cryoelectron microscopy using different forms of vaccinia virus. Using this
approach we show that treatment of purified IMV with the reducing agent D17 disrupts the
IMV in a reproducible fashion; it appears to loosen the interactions between the two outer
membranes and thereby facilitates a peeling off of the cisterna. In this process a 39 kD core
surface protein (Table 1) that is inaccessible to its antibody in intact IMV, becomes exposed. By
use of structural disruption of the EEV, we could also confmn that this viral form contains one
additional membrane (relative to the IMV) in which the spanning membrane protein, p42, (Table
1) is exposed on the outside. A second integra} membrane protein, p37, (Table 1) is
cytoplasmically buried in the space between the surface of the IMV and the EEV membrane.
Collectively, our data suggest that, if the EEV fuses with a cell and releases an intact IMV into
the cytoplasm, the presence of a reducing environment may be sufficient to induce an uncoating
of the IMV into the transcription-competent core stage.
RESULTS
Our rationale in this study was to gain insights into the way vaccinia IMV and EEV are
assembled. In order to achieve this we used a controlled process of disassembly of the viral
particles and an electron microscopical preparation procedure in which the resulting viral
structures are best preserved. Clearly, the best method which satisfied these requirements was
the "fully-hydrated" method for cryoelectron microscopy (Dubochet et al., 1988). However,
unlike most (periodic) viroses that have been studied by cryo EM (e.g. Stewart at al., 1991) both
forms of vaccinia are relatively large. The roughly brick-shaped particles have approximate
dimensions of 350 x 250 x 150 nm and are thus, perhaps, at the limit for this method. Since both
infectious forms show at least two membrane profiles, it was clear that for interpreting the
images the use of antibodies against proteins known to be localised to specific parts of the virus
would be needed.
Whereas, for small viral particles, any bound IgG molecules, or even individual Fab fragments
can be resolved without additional markers, for a large particle such as vaccinia an electron dense
marker was essential. For this purpose, 5 and 10 nm gold particles conjugated to protein A were
used for most experiments. We frrst visualized, either (unlabelled) intact IMV or viral cores
(operationally defined), prepared using NP40 plus D17, by cryo EM. Treatment of IMV
particles with NP40 and a reducing agent such as D17 is a classical procedure for preparing
vaccinia core particles (Joklik, 1964; Easterbrook, 1966) that are transcription-active in vitro
(Kates and McAuslan, 1967). For both types of particles (IMV and cores) the images obtained
(Fig. lA, B and C) are similar to those observed by Dubochet at al. (1994) with the IMV
displaying two electron dense layers that are presumably membranes. The space between these
layers contains the = 20 nm spike-like projections. When the cores were visualized, these spikes
were visible as projections on their surface (Fig. IB, C). In addition, we observed an additional
set of spike-like protrusions of an average length of about 8 nm on the surface of the IMV (Fig.
5A). The molecular identity of these structures is unclear at present.
For immunogold labelling we frrst used two antibodies that recognise proteins on the surface of
the IMV, namely the peripheral membrane protein p14 and the integral membrane protein p32
(Table 1). For labelling the surface of the viral core we used an antibody against p39 (Table 1) a
protein first described by Rodriguez et al. (1987) and which we have characterized in more detail
(Cudmore et al., manuscript in preparation). In the latter study labelling of viral particles
followed by negative staining shows clearly that a-p39 does not label the intact IMV but strongly
labels the surface of the (NP40 plus DTI-treated) viral cores. Antibodies against this protein also
label the surface of the isolated natural cores that appear in the cytoplasm during the viral
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infection process (Snijder et ale in preparation). These observations are confirmed in the present
study (see below).
Treatment of IMV with DTT
The two membranes in the immature virus IV are so tightly apposed that they appear as a single
membrane in most thin section images (see Sodeik et al., 1993; Dales and Pogo, 1981).
However, in the IMV two distinct layers are evident in both thawed cryosections of aldehyde-
fixed cells and by cryo EM of intact IMV virus. (Fig. 2A; Sodeik et al., 1993; Dubochet et al.,
1994; see also Dales and Pogo, 1981). Prominent spike-like structures are especially visible in
the space between these two layers in vitrified IMV preparations (Dubochet et al., 1994; Fig.
2B). The question therefore arises whether the two tightly apposed membranes seen in the IV
separate in the IMV. In this case, the spike-like projections would be lumenal structures that
perhaps cross-link the two membranes of the cisterna (Fig. 2, model B). Alternatively, the IMV
has an outer layer that, as in the IV, is actually composed of two tightly-apposed membranes and
it possesses an additional electron dense layer close to the viral DNA. If this is the case, the
spikes must be cytoplasmically-disposed structures, that might cross-link the inner, cytoplasmic
surface of the cisterna with the surface of the core outer layer (Fig. 2, model A).
To try to resolve this issue we looked for treatments that would disrupt the organization of the
different layers, without destroying membrane structure. Inspired by the work of Easterbrook
(1966) we found that the most striking effect was obtained using OTT, a treatment we expected
to disrupt anz disulfide bonds in the virus. The same effects were also seen with 2-b-
mercaptoethanol (results not shown). As shown in Fig. 3 incubation of IMV on the EM grid
with 20 mM OTT for short periods (5-30 min) resulted in a statistically significant swelling of
the IMV (untreated average (n=25): length 338 nm ± 13 om (S.D.), width 267 om ±18 om
(S.D.); treated average of the non-disrupted particles (n=25): length 356 nm ± 15 nm (S.D.),
width 289 om ± 15 nm (S.D.). Under this condition the IMV surface antigens p14 (not shown)
and p32 (Fig. 4) remained fully exposed, with essentially no labelling seen with the antibodies
against either p39, or with a control, irrelevant antibody. However, with increasing times of
treatment a higher percentage of particles became disrupted and the particles labelled for p39 (see
below). Representative images of this disruption process are shown in Fig. 3.
The disruption of the IMV with OTT was also visualized by a number of novel modifications of
the bare-grid method. First, the virus could be chemically cross-linked using brief exposures
(seconds to minutes) to low concentrations of aldehydes (not shown). This approach became
more important for the studies with the EEV (see below). Second, the viruses, either with or
without OTT treatment, could be exposed for a few seconds to low concentrations of uranyl
acetate, which was subsequently replaced by pure water prior to freezing (positive staining; Fig.
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3 F-I, Fig. 4). This treatment showed that whereas intact IMV were refractory to the stain, the
stain clearly entered the particles that had been affected by DIT. Figure 3 shows different images
of the DTI-induced disruptioR, a process which ultimately exposes the viral core, and thus may
resemble the natural uncoating process that occurs during infection. In addition to the swelling
with DIT we also noted a separation of the outer membrane(s). This separation process often
apPeared to be initiated at the comer of the particle (Fig. 3A, 3F). In Fig. 30 the two membrane
profiles of the outer cisterna are evident (see also Fig. 3E), while Fig. 3F, 30 and 31 suggest that
DTI induces a Peeling off of this outer cisterna. In some cases this outer cisterna forms long, 20
nm diameter tubules resembling the so-called "surface tubular elements" first described by Stem
and Dales (1976). In all cases where disruption occurred the surface of the core became exposed,
as evident by the core spike elements (Fig. 3 panels A, C, D, E, F, H, I). Occasionally, the cores
themselves also appear to become disrupted by DIT (Fig. 31).
In order to examine this DIT-induced uncoating process in more detail we next analysed the
pattern of labelling for the IMV surface antigens p14 and p32 and the core surface protein p39
(see Table 1) on such disrupted particles. A summary of the key fmdings is as follows: p39 was
localized exclusively to the exposed core, identified by the presence of the 20 nm spike-like
projections on their surface (Fig. 5, panels E-F). In contrast, antibodies against the surface
membrane proteins p14 and p321abelled only the outer membrane of the IMV (Fig. 5, panels A-
D). Following disruption of the outer cisterna, the labelling for p14 and p32 was restricted to the
membrane fragments that were attached to the cores devoid of labelling. The labelling density
seen on such membrane fragments was similar to that seen on the surface of intact IMV.
In the next series of eXPeriments we asked whether the approach introduced here for single
immuno-labelling could also be applied for a double labelling procedure. For this the IMV was
first labelled with antibodies against one of the surface membrane proteins p14 or p32 (Table 1)
followed by protein A-gold. The IMV was then treated with DTf, briefly fixed (less than 1 min)
with glutaraldehyde (Slot et al., 1991) and then labelled with an antibody against another vaccinia
protein, or with control antibodies, followed by a different size protein A-gold complex. As
shown in Fig. 4 this double labelling procedure facilitated a visualintion of the disruption of the
IMV by DIT. Whereas the outer membranes labelled for p14 and p32, the core, which became
exposed following disruption, could be specifically labelled only with a-p39 (Fig. 4C). The
findings that DIT treatment leads to the exposure of epitopes on a core surface protein argues
strongly for model A rather than B in Fig 1.
Protease treatment of IMV
The above experiments with D1T suggested that the outer membrane of the IMV might not
form a completely uniform cover around the IMV, that is, that the outer cisterna that enwraps the
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viral core may not have fused with itself (Fig. 1, model Ai). We therefore asked whether this
cisterna could be sealed by a proteinaceous structure such as a 'pore' or 'focal contact' (Fig. 1,
model Ail or iii). If so, such a structure might be accessible to protease treatment. In extensive
(unpublished) studies with proteases we had noticed that different IMV preparations behaved
very irreproducibly towards proteases. In many eXPeriments relatively high concentration of
proteases digested IMV surface protein (such as p14) without affecting core proteins such as p4a
or p39; in others, however, core proteins became digested within ( 2 hrs of treatment.
We therefore carried out a systematic study using two proteases, proteinase K (4°C) and trypsin
(37°C) and assayed their effects both by biochemical analysis and by negative staining EM (Fig.
6). We emphasize that the goal of the latter approach in this study was simply to evaluate
whether or not stain entered the particle, not to provide any structural details. Whereas the
majority of intact IMV particles exclude stains such as uranyl acetate this stain can enter particles
that have been disrupted, for example, with OIT, as mentioned.
IMV were treated with 100 or 200 (g/ml of either proteinase K at 4(C or trypsin at 37(C for
either 1 or 2 hrs. In this eXPeriment, treatment with 200 (g/ml proteinase K (4(C) for 2 hrs, a
concentration which completely digested the surface protein p14 after 30 min, failed to
significantly digest the core proteins (not shown). Similarly, by negative staining there was little
difference in the staining apPear8llce between untreated particles and those treated with 200 (g/ml
proteinase K for 2 hrs (Table 2). In the case of trypsin at 37°C all treatments completely
removed the surface protein p14 (Fig. 7). In contrast, at least 2 hrs was needed to show visible
signs of degradation of the core proteins p39 and p4a. By 4 hrs these proteins were essentially
completely digested (Fig. 7). These results were again complemented by the EM negative
staining approach (Table 2). The images from this eXPeriment also showed a significant fraction
of particles that were obviously disrupted after 2 hrs although many apparently intact particles
that either excluded or included stain were also seen (Fig 6). In some eXPeriments 100-200 (g/ml
proteinase K for 2 hrs at 4°C also led to an oPening of the majority of the particles as seen by an
immunoblotting analysis ofp39 and p4a (not shown). Collectively, these data argued that
whereas the IMV has an inherently high resistance to proteases, at a certain threshold of activity
the particle opens. The simplest interpretation of these data is that the outer cisterna of the IMV is
sealed by a proteinaceous structure although other interpretations cannot be ruled out. We stress
that we have not yet seen any convincing evidence of any potential pore or other notable local
structures on the IMV surface by cryo EM.
Extracellular Enveloped Virus (EEV)
The extracellular form of the IHD-J strain of vaccinia was purified from the medium of (the
relatively high EEV yielding) rabbit RK13 cells and examined by cryo EM. In agreement with
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the current ideas on this viral form, these particles apPeared to have one additional membrane
bilayer that was clearly resolved (Fig. 8A). However, in only few EEV particles did this
membrane uniformly and tightly surround the particle and even in this case the interaction
between the outer membrane and the underlying IMV was rather loose. In most cases the
membrane appeared to have little contact with the IMV and was often disrupted (Figs. 8A; see
also Payne and Kristenson, 1979). A briefflXation (seconds) of the EEV adsorbed to the grid
with 0.5% glutaraldehyde increased the fraction of intact EEV particles considerably. When the
outer membrane was completely removed the surface of some of the underlying IMVs was
much rougher in texture (Fig. 8B) than the surface of purified IMV (Fig. lA). This surface
appearance of the IMV resembled the structures described earlier as surface tubular elements by
Stem and Dales (1978). The significance of these structures remains to be established.
Because of this tendency for the EEV to disrupt we decided to investigate the topology of some
key membrane proteins using the immunogold method in the absence of any treatment. In any
one preparation one could clearly identify both intact and disrupted particles. In these
experiments the structure of underlying IMV was rarely affected (except for the sometimes
rougher surface texture, as mentioned).
ImmunolabeUing of EEV
For the BEV we selected two antibodies which pilot experiments revealed to be especially
interesting. The fIrSt was p42 (Table 1) (Englestadt et al., 1992; Isaacs et al., 1992; Wolffe et al.,
1993). This protein is enriched in TGN-derived membranes that wrap around the IMV to form
the lEV, the precursor of the EEV (see Fig. 9). According to current ideas the lEV fuses with
the plasma membrane, thereby releasing the EEV (payne, 1980; Schmelz et al., 1994). As a
result lumenal epitopes that are buried within the wrapping cisterna become exposed on the
surface of the EEV (see Fig. 9).
The bulk ofp42, like the haemagglutinin (Shida 1986; Schmelz et al., 1994) should be exposed
on the outside of the EEV with the predicted small cytoplasmic domains of these proteins lying
directly above the IMV. As expected from this model, a monoclonal antibody against p42
labelled the outside of the outer membrane of the BEV (Fig. 80). In those cases where the
membrane was disrupted, the newly exposed surface was clearly devoid of labelling (not
shown). However, this newly exposed surface, as expected, labelled strongly for the IMV
surface protein p14 (Fig. 8e). The second interesting protein we examined in the BEV was p37
(Table 1) (Payne, 1978; Hiller and Weber, 1985; Hirt et al., 1986) that is essential for IEVIEEV
formation (Blasco and Moss, 1991). The available biochemical data argue that this protein,
which has covalently bound palmitate, is an integral membrane protein, although it has not been
established whether the protein is inserted into the rough ER or, as favoured by Hiller and Weber
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(1985) based on immunofluorescence microscopy analysis, whether it somehow inserts directly
into Golgi membranes by a post-translational mechanism.
Labelling of thawed cryo sections of vaccinia infected cells shows that GolgilfGN as well as the
wrapping membranes and the EEV are enriched for p37 (Schmelz et al., 1994). The data
obtained using a combination of immunogold labelling for p37 followed by cryo EM argue that,
in the BEV this protein is localized to the space between the outer membrane and the surface of
the IMV. Thus, the a- p37 had no access to its antigen in intact EEV (in contrast to the a- p42 )
but following disruption/vesiculation and resealing of the outer membrane there was strong
labelling of now exposed cytoplasmic side of the membrane (Fig. 8E). These data are
summarized schematically in Fig. 9).
DISCUSSION
In the present paper we have studied the structure of vaccinia viros by cryo EM, and in particular
taken advantage of a recent finding by Cyrklaffet ale (1994). This shows that particles floating at
the water-air interphase on a holey EM grid will remain there for the time needed to replace all
the solutions simply by gentle changes of the underlying solvent. Here, we adapted this
technique for combining the advantages of immunogold labelling with the high resolution
structural preservation that is routinely obtainable using cryo EM (Dubochet et al., 1988).
Using this novel approach we investigated both the structure and the topology of some key
proteins in both the IMV and EEV forms of the poxviros vaccinia, which probably represents
the most complex form of all viroses. For the IMV our work extends the preliminary findings of
Dubochet et ale (1994) who fIrSt described the appearance of the IMV by cryo EM. The images
in the latter reference supported the notion that the IMV has two membrane-like 'layers'.
Further, they confrrmed earlier data from negative staining EM that there are prominent, spike-
like projections visible in IMV in images ofconventional thin sections, as well as in vitrified
preparations, which appear to be on the surface of viros treated with NP40 plus OIT, the
chemically prepared viral 'core'. The latter view is supported by our data in this study which also
show a correlation between the presence of the spikes on the core surface, that is exposed by
OIT treatment, with a strong surface labelling for p39. Both the presence of spikes as
morphological entities, as well as labelling of their surface with a- p39 is also evident on the
natural viral cores isolated during the infection process (Snijder et ale in preparation). The strong
labelling for p39 on the surface of the NP401D'IT-prepared cores, on the core surface exposed
after OTT alone, as well as on the 'natural' cores, argues that the same surface becomes exposed
in all three conditions.
The model which emerges from the present study, in conjunction with our earlier data (Sodeik et
al., 1993), is shown in Fig. 2A. This model argues that the tightly apposed cisterna which
incompletely surrounds the spherical IV overlays the major spike-like projections that protrude
from the surface of the viral core. This scheme is the simplest way to explain how OIT leads to
the exposure of epitopes for p39, which is a cytosolic protein, on the surface of the core. We
presume that OIT, a potent reducing agent, disrupts intra-lumenal disulfide bounds that stabilize
the membrane-membrane interactions of the cisterna. According to current dogma, disulfide
bonds can only form in the oxidising environment of the endoplasmic reticulum and not in the
highly reducing environment of the cytosol (Hwang et ale 1992, Doms et ale 1993). The images
of the OTT-induced disruption process lead us to suggest that the IMV outer cisterna does not
fuse with itself but is rather interrupted in some way.
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The notion that the outer cisterna of the IMV is not fused together (as in Fig 2Ai) was also
supported by the experiments with Proteases showing that, whereas the IMV particles resisted
relatively high concentration of protease for relatively long periods, above a certain threshold of
protease activity viral core proteins became almost completely accessible to digestion. We
tentatively propose therefore that the IMV outer cisterna is 'glued' together by a (relatively
protease-resistant) proteinaceous structure. Since we have failed to see convincing evidence of
any 'pore' structure (Fig 2Aii) by cryo EM we speculate that the ends of the cisterna may be
sealed by a protein 'plug' or 'focal contact' that tightly glues the end of the cisterna with the rest
of the (same) cisterna (Fig lAiii).
The second important question raised by this study is the nature of the membrane-like electron-
dense layer that is clearly seen beneath the spike layer of the cores, both in vitrified specimens
(Dubochet et al., 1994; this study) and in thawed cryosections ofIMV (Sodeik et al., 1993). We
intend to address this question, is it a membrane, by analysing the biochemical composition of
cores produced during the infection process. As shown in this study an obvious candidate
protein that may at least compose part of the core surface spikes is p39.
The ability of reducing agents to simulate an uncoating process may be of physiological
significance. The available data on the infection process for both IMV and BEV, while not
defmitive, have been interpreted as evidence for a fusion process in both cases (Granados 1973,
Annstrong et al., 1973; Chang et al., 1978; Payne and Norrby, 1978; Doms et al., 1990). If the
BEV fuses with the plasma membrane it would release an intact IMV into the cytoplasm. Our
data now provide a plausible explanation for how such viruses could begin to disassemble as
soon as they are exposed to the reducing environment of the cytosol. Such a view would also
agree with the studies of Munyon et al (1967), who showed that, while intact IMV cannot
undergo the remarkable in vitro transcription process that is observed with pure cores, treatment
of IMV with either DTT or 2-b-ME (in the absence of detergents) also leads to significant
increases in the measured in vitro transcription rates.
The novel cryo EM approach also provided interesting data with respect to the EEV. Whenever
we have isolated this form and examined it by either negative staining or, following aldehyde
fixation by cryo sectioning, we were always surprised at the extreme lability of these particles.
Unexpectedly, this lability was also evident in the cryo EM images, even when the virions were
taken from the extracellular medium without centrifugation and in the absence ofchemical
fixation. That aldehyde fixation facilitated the preservation of these particles suggests that at least
a part of the dismption we observed occurs during the storage and/or labelling steps. Only a
minority of the particles had a complete and intact outer membrane and, even in those cases, this
membrane did not appear to interact tightly with the surface of the IMV. The presence of this
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loose outer membrane on the physiologically most important infectious form of vaccinia (Payne,
1978) is surprising. In the simplest model one might argue that this outer membrane is simply a
transient coat that is lost to expose the IMV prior to infection. However, such a phenomenon
would be difficult to reconcile with eXPeriments showing that antibodies against IMV block
infection of the IMV but fail to prevent infectivity of EEV particles (Appleyard and Andrews,
1974; Payne, 1980). ). This view is also inconsistent with the fact that purified BEV enter cells
more rapidly than does the IMV ( Payne and Norrby, 1978; Doms et al. 1990). Moreover, there
are significant differences in the susceptibility of IMV and EEV to both temPerature and
metabolic inhibitors (Payne and Norrby, 1978).
A possible solution to the apparent paradox that the most infectious form of vaccinia is
surprisingly labile, at least relative to the more robust IMV, comes from older (Stokes 1978,
Hiller at al. 1979) and more recent (Cudmore et al., 1995) observations on the mechanism by
which the EEV exits from infected cells. These data argue that the lEV, the intracellular
precursor of the EEV, is proPelled through the cell by an actin-based tail structure (Cudmore et
al., 1995) similar to the structure fIrst described for Shigella (Clerc and Sansonetti, 1987) and
subsequently for Listeria (Tilney et al., 1989; Theriot, 1994; see Cossart 1995 for a review). The
actin tail then somehow prOPels the lEV to the tip of a newly formed microvillus. One can
speculate that the lEV subsequently fuses with the plasma membrane at the tip of the
microvillus, releasing the EEV to the outside. Thin section EM images suggest that the EEV
remains attached to the plasma membrane for extended Periods since they are relatively easy to
find in thin sections. The EEV can then fuse with and infect a neighbouring, uninfected cell. In
this scenario an important extracellular role of the EEV would be as a transient and Perhaps
predominantly cell-associated form that facilitates rapid cell to cell transfer. In further agreement
with this view is the recent identification of a distinct class of plasma membrane-attached BEV,
the CEV (cell associated virus) form (Blasco and Moss 1992).
Our immunolabelling data on the EEV fit clearly into existing models. Thus, the EEV has one
extra membrane relative to the IMV and that membrane is enriched in p42 (Engiestadt and
Smith, 1993; Schmelz et al., 1994), p21 (Duncan and Smith, 1992; Payne, 1992), the
haemagglutinin (HA) (Shida, 1986) and a recently identified 43-50 leD membrane protein
(parkinson and Smith, 1994). All these proteins are predominantly exposed on the outer surface
of the EEV and, for p42 we show this directly in this study. More significantly, we showed that
p37 (Hiller et al. 1981; Hiller and Weber, 1985; Schmelz et al., 1994, Schmutz et al., 1991) is
exposed to its antibody on the inner asPect of the outer membrane of the BEV only following
disruption, in agreement with the recent biochemical data of Schmutz et al. (1995). This protein
has been postulated to interact with a protein(s) on the surface of the IMV. The best candidate for
the latter is, as previously proposed by Rodriguez and Smith (1990), P14, which here became
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exposed to its antibody only following disruption of the outer membrane of the EEV, as
eXPeCted if the outer membrane directly covers the surface of the IMV.
We believe that the novel approach of immunogold labelling, in combination with cryo EM of
vitrified particles will be a useful approach for any particle in the range of 50 - 500 DID. Since the
antibody-gold complex is relatively large (minimum size = 20 om) we emphasize that this is not
a high resolution labelling technique Per see Available methods that could be applied to improve
the spatial resolution of the immunolabelling would give only modest, but nevertheless
important gains (Griffiths, 1993). However, by combining the immunolabelling with methods to
disrupt or digest biological particles in a controlled fashion, we believe this approach can best be
used for identifying layers or domains in other complex macromolecular structures such as
nuclear pores, centrioles, kinetochores, or Perhaps defmed fragments of chromosomes, under
conditions which avoid most of the artefacts associated with more conventional EM methods.
MATERIALS AND METHODS
Antibodies and protein A-gold: The following antibodies were used. Mouse monoclonal a-
p14 (Dallo et al., 1987; Sodeik et al., 1995) provided by Dr. M. Esteban; rabbit a -p39 provided
by Dr. M. Esteban; mouse monoclonal a -p42 (Schmelz et al., 1994) provided by Dr. G. Hiller
and mouse monoclonal a -p37 (Schmelz et al., 1994); provided by Dr. G. Hiller). Protein A-
gold was purchased from Dr. Jan Slot (University of Utrecht, Stichting MEMO, Utrecht,
Netherlands).
Cells and viral strains: Preparation of IMV: Hela cells (ATCC CCL2) were grown in Eagle's
minimal essential medium (MEM) supplemented with 10% fetal calf serum (heat-inactivated),
non-essential amino acids, 2 mM glutamine, 100 U/mI penicillin and l00flg/mI streptomycin.
The cells were grown as adherent cultures at 37°C in a 5% C02 incubator for two days to 80%
confluency. For the preparation of purified IMV we used both wild type WR virus and a WR
deletion mutant (vRBI2), lacking the EEV protein p37 (gene FI3L; Blasco and Moss 1992) that
fails to produce lEV and EEV. Since this deletion mutant does not readily spread from cell to
cell, special care was taken to infect cells at relatively high multiplicity of infection (MOl). The
use of this vRB 12 mutant ensures that IMV preparations are devoid of EEV particles.
The routine procedure was to infect 4 flasks (175 ml) at a MOl of approximately 3 for 48 hrs,
after which the IMV was released by freeze-thawing. This virus preparation was used to infect 6
plates (24 x 24 cm) of 70% confluent Hela cells. This generally led to complete cytopathic effects
(CPE) at 48 hrs post-infection. The cells were harvested by scraping and centrifuged for 10' at
1500 rpm. The cells were broken with 12 strokes of a dounce homogenizer and the nuclei
removed by centrifugation at 1000 g. The IMV was subsequently purified by pelleting at 24000
rpm through a 36% sucrose cushion (in 10 mM Tris pH 9.0), followed by sedimentation at
15000 rpm for 17 min in a 25-40% sucrose gradient using an SW27 rotor and the subsequent
band finally concentrated by pelleting for 30' at 24000 rpm in a SW40 Beckman rotor. (Doms et
al., 1990). Such IMV preparations usually contained from 1010-1011 particles/mI. All cell
culture material was obtained from Gibco, OIBCO BRL (Gaithersburg, MD).
Preparation of EEV: Most of the virus present in the medium from infected cells 24 hrs post-
infection is BEV (Payne and Kristenson, 1979). Since EEV is a very fragile form of vaccinia
and has the tendency to loose its outer membrane when exposed to mechanical stress we tried to
avoid any unnecessary manipulation. For many, but not all experiments, we took the EEV
directly from the medium ofIHD-J infected RK13 cells 48 hrs after infection without further
purification (Payne 1979). In order to increase the number of viral particles, we reduced the
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amount of medium to a minimum. Confluent monolayers in 25 cm2 flasks were infected with
llID-J and incubated in 2 ml of MEM containing 2.5% foetal calf serum. Sometimes the
medium was clarified by low speed centrifugation and the amount of free virions in the medium
estimated by negative staining.
Partial disruption of virus particles: For this, the particle suspension was applied to a
perforated carbon grid, allowed to adsorb for 3-10 min depending on particle concentration. The
grid was than washed briefly in 10 mM Tris pH 9.0 and incubated on 20 mM DTT in 10 mM
Tris pH 9 at 370C or room temperature for 5-30 min in a humid chamber. The grids were
subsequently rinsed with 10 mM Tris buffer (pH 9) and either frozen immediately or used for
further labelling experiments as described below.
Protease digestion studies: Sucrose gradient purified IMV was mixed with an equal volume of
200 or 400 flg/ml trypsin, in 10 mM Tris, pH 9, containing 20 mM CaCI2. Alternatively 200 or
400 flg/ml protease K on ice was used. Final concentrations of proteases used were 100 or 200
flg/ml. Incubation at 37°C was continued for 30, 60, 120 or 240 min. Subsequently, digestion
was blocked for 10 min on ice using 1 f.1l of aprotinin stock solution (4 mg/ml) and 1 f.1l of
bovine trypsin inhibitor (20 mg/ml) (Sigma) in the case of trypsin or 2 mM PMSF (Sigma) for
the protease K. The samples were snap frozen in liquid nitrogen and stored at -20°C before
analysis using 15% SDS-Page. Samples were rapidly thawed by incubation at 95°C with
Laemli sample buffer, the gels ron and the proteins transferred to nitrocellulose and blotted for
p39 p14 and 4a (a gift from Dr D Hruby - see vanSlyke et al., 1991), as described (Ericsson et
al.,1995)
For negative staining aliquots of the vims plus protease were adsorbed to glow-discharged,
carbon-coated grids, rinsed briefly with distilled water and negatively stained with 2% uranyl
acetate.
Labelling of virus particles: Labelling experiments were perfonned as follows: after the 3-5 ml
drop of particle suspension had been left for a given time on the grid (the side coated with the
perforated carbon film), the grid was washed on 1 ml droplets of Hepes buffer (100 mM pH
7.4) four times for 2 sec and once for 2 min. The grid was subsequently placed on a small
droplet (5-10 ml) of antibody solution for 15-30 min followed by a further washing step with
buffer (4 x 2 sec and 1 x 2 min). The grid was then subjected to a protein A-gold solution for 15
min, washed (4 x 2 sec and then 2 x 2 min). In the case where antibodies which do not bind to
protein A (i.e. mouse primary antibodies) were used, the grid was incubated on a secondary
antibody solution, prior to another washing step before it was exposed to the protein A-gold
solution. For double labelling we followed the general regime used for labelling of cryosections
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with somewhat reduced incubation times. Blotting and vitrification took place as described below
(Slot et al., 1991). In the few cases where we tested the use of fixatives the grids were either
placed briefly (sec-min) on drops of formaldehyde solution (4% in HEPES 100 mM, pH 7.4) or
glutaraldehyde solution (0.5% in HEPES 100 mM, pH 7.4).
Specimen preparation for cryoelectron microscopy: The thin film vitrification method is
described in detail elsewhere (Dubochet et al., 1988; Roos & Morgan, 1990). A 3-5 ml droplet
of suspension was put on a grid supporting a perforated carbon ftIm with hole diameters
between 2 and 5 nun. The drop was left on the grid for 1-3 min in the case ofIMV and up to 10
min in the case of EEV. Blotting paper (Whatmann Dr. 1) was then frrmly applied to one side of
the grid for about 1 sec. The plunger holding the grid was immediately released and, within
about 0.1 sec, the grid was plunged into a liquid ethane slush cooled with liquid nitrogen, thus
vitrifying the thin liquid film.
Cryo-electron microscopy: The vitrified samples were either stored in liquid nitrogen or
observed immediately. Transfer and observations were made with a side entry, cryo-transfer
holders (Gatan 626 (Gatan, Varrendale, Pa) and Oxford Instruments, Cf-3500(Oxford
Instruments, Oxford, UK) in a specially adapted cryo-electron microscope the Jool-2000EX
(JEOL, Tokyo, Japan, equipped with a Gatan TV camera, model 622-0600 with an image
intensifier). The microscope has an efficient blade-type anti-contaminator. Observations were
made under minimum irradiation conditions at magnifications ranging from X 3000 to 40000
and at 3.5-10.5 nun under focus. Micrographs were recorded on Kodak: 50-163 electron
microscopy ftIm and developed in full strength 0-19 developer for 12 min (speed: ca. 2.2
J.UI12Ielectron x 00 unit). Magnification was calibrated with a cross-grating replica, with an
estimated error of 2%.
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TABLES
Table .1
Virus
IMV
EEV
Protein
pl4
p32
p39
p37
p42
Gene
A27L
D8L
A4L
F13L
B5R
Location
outer surface of IMV cisterna
outer surface of IMV cisterna
surface of the core
inner surface of the outer membrane of EEV
surface of the EEV
Table 2
DISRUPTED
6
INTACT
89
Effect of proteases on IMV as seen by negative staining
% of total*
'OPEN'
6Control
Proteinase K:
100 Jlg - I hi' 88 9
200 Jlg - I hr 85 10
100 Jlg - 2 hi' 89 1
200 Jlg - 2 hr 83 2
Trypsin:
100 Jlg - I hi' 92 4
200 Jlg - I br 75 6
100 Jlg - 2 hi' 71 25
200 Jlg - 2 hi' 8 27
3
5
10
IS
4
19
4
65
*For each value a total of 200 particles were counted. Examples of intact particles as well as
particles that appear intact but 'open' to stain are shown in Fig. 6A. Disrupted particles were
defined as particles with gross morphological alterations (see Fig. 6B).
FIGURE LEGENDS
FIG. 1. Vitrified IMV particles: (A) untreated IMV particles, (B) and (C) isolated cores after
NP-40 I 017 treatment. The large arrows show the outer membrane of the IMV, while the large
arrowhead indicates the core outer layer. The small arrow points to the IMV surface spike
projections, while the more prominent 20 om spike on the surface of the core is indicated by
small arrowheads. The asterisk depicts one of the very few partially disrupted IMVs found. We
believe the extraneous material surrounding the cores in B and C represents remnants of the
outer cisterna which are not extracted by the detergent.
(bar =100 nm)
FIG. 2. Models of IMV formation and location of key proteins in relation to the enwrapping
membranes of the intermediate compartment (IC) that we propose to be directly continuous with
the rough endoplasmic reticulum (RER). The upper part of this model is based on our previous
study (Sodeik et al., 1993); see Griffiths and Rottier, 1993 for review) and argues that the IV is a
highly-apposed cisterna derived from the IC. In model A the key point is that the IV cisterna
remains tightly apposed to and overlies the spikes which are on the surface of the core. A
second set of (8 om) surface spikes is evident on the surface of the IMV. In model B the spikes
are shown as lumenal structures. In both models OTI is envisaged as having its effect by
reducing intra-lumenal S-S bonds and thereby affecting intra-lumenal protein-protein
interactions. In model A the composition of the core ''membrane'' is left open, while in B it
represents the inner membrane of the IV-derived cisterna after a process of separation. The
results in this study argue strongly against model B. Nevertheless, the precise structure of the
outer surface remains to be solved. Based on both the structural data and the accessibility of core
proteins to proteases, we suggest that the cisterna is not fused with itself (Ai) but may be glued
together by a proteinaceous plug. The absence of any structural data for a 'pore' (Aii) makes us
favour the view that the putative proteinaceous structure may be covered by an overlap in the
cisterna (Aiii).
FIG. 3. Effect of 20 mM OTI at 370C for 10 min (panels (B), (C), (F) and (G» or 30 min
(panels (A), (0), (E), (H) and (I) on intact IMV. Panels (A)-(E) show unstained cryo EM
preparations, while (F}-(I) are preparations stained for a few seconds with 0.3% uranyl acetate.
The initial effects of OTI include swelling of the outer cisterna (B, 0, G). Subsequently the
particle appears to uncoat (A, C, 0, E, F, H, I) exposing the major core spike (small
arrowheads). In panels (G) and (E) the small arrows reveal the two membranes of the outer
cisterna. In (F) the large arrowheads indicate the ends of the cisternae that apPear to be Peeling
off the core surface. The tubule seen in (0) (arrow) is probably an artefact of the orr induced
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uncoating process that resembles the surface tubular elements seen in classical negative stain
images.(bar =100 om)
FIG. 4 (A) and (B) show IMV particles treated with OTT (20 mM for 10 min) and labelled for
p32. In (A) the particles are swollen while in (B) disruption is evident. The preparation in (B)
and (C) is stained with 0.3% uranyl acetate. The arrowheads indicate the ends of the outer
cisterna. (C) shows a double labelling eXPeriment. The intact IMV was fust labelled with p32
followed by 5 om proteinA-gold. The particles were subsequently treated with 20 mM OTT for
10 min and labelled for p39 followed by 10 om proteinA-gold. The image selected shows two
intact particles (left) adjacent to a released core (asterisk). Whereas the intact IMV labels strongly
for p32 the core labels strongly for p39.
FIG. 5. (A) shows undisrupted IMV particles labelled with a-pI4. (B) (C) and (0) depict IMV
particles exposed to OTT (20 mM for 30 min at 37OC) prior to immuno-Iabelling with a-P14
while (E) and (F) show labelling for p39. These data show that a-p14 labels the outer membrane
of IMV but not the exposed core, whereas a-p39 labels the core but not the outer membrane.
(bar = 100 om)
FIG. 6. Negative staining of vaccinia virus IMV. A shows a control virus preparation with two
intact (I) particles that exclude stain and one OPen (0) but stmeturally intact particle that stain has
entered. B is from a preparation treated in susPension with 200 Jig/ml trypsin for 2 hrs showing
one particle that we classify as nonna! and intact (I). The remainder either apPear disrupted or
include stain. The star indicates a side view of a particle into which stain has entered. Bars 100
nm.
FIG. 7. Protease treatment of purified IMV. The vims was treated for different times with two
concentrations of trypsin at 37OC. Immunoblots are shown for the core proteins, p39, 4a and the
IMV surface protein, p14. While the outer surface protein p14 is completely digested at the
earliest time points, p39 and 4a resist significant degradation until 2 hrs. After 4 hrs both
proteins are essentially completely digested.
FIG. 8. Cryo EM ofEEV. The EEV has one additional membrane relative to the IMV (Fig. 2A
). The outer membrane (small arrowheads) is extremely fragile in isolated preparations.(A)
untreated EEV; this preparation was taken directly from the extracellular medium of infected
RK13 cells without centrifugation and vitrified. The asterisk depicts one of relatively few
particles where the outer membrane remained intact. Very often they appear as shown in (B). In
this example the outer membrane has been removed exposing the outer surface of the IMV. We
have no explanation for the ruffled a.pPe8J'81lCe of these particles which contrasts with the smooth
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appearance of isolated IMVs (see Fig. 2A) but note the resemblance to the so-called surface
tubular elements seen in classical negative stain preparations of IMV. In (C) the preparation was
labelled with a-p14. Whereas this protein is not exposed in undisrupted particles, following
disruption (in this case partial disruption) the epitopes for p14 are exposed and accessible for
labelling. (D) shows particles that have been immuno-labelled with a-p42 showing the strong
surface labelling on the outside of the EEV. (E) Whereas intact EEV does not label with a-p37,
disrupted particles expose the cytoplasmic aspect of the outer membrane and become labelled.
(bar = 100 om)
FIG. 9. Model to show the membrane topology in the lEV and EEV. The IMV acquires two
additional membranes from the TON to form the lEV. The outer membranes of the lEV is lost
upon fusion with the cell membrane and the EEV released into the extracellular medium. The
bulk of p42 and HA are in the lumen of the lEV and become exposed on the surface of the
BEV. In contrast p37 is cytoplasmically disposed and is not exposed on the surface of the EEV
unless the particles are disrupted. p14, which covers the surface of the underlying IMV, may
interact with p37 although, until now, no evidence for such an interaction has existed.
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